Hypo-osmolality and hyponatraemia

E4_HYPOOSMNAT

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — E87.1 Hospital discharge: ICD-9 — 2761 Cause of death: ICD-10 — E87.1 Cause of death: ICD-9 — 2761 2 out of 7 registries used, show all original rules.	7270
4. Check minimum number of events None	7270
5. Include endpoints None	7270
6. Filter based on genotype QC (FinnGen only)	7270

Control definitions (FinnGen only)

Control exclude: E4_METABOLIA

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: E87
Name in latin: Hyposmolalitas

NAME	E4_HYPOOSMNAT
CONTROL_EXCLUDE	E4_METABOLIA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	E871
HD_ICD_9	2761
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	E871
COD_ICD_9	2761
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Hypo-osmolality and hyponatraemia based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	74063	47522	26119
Only index persons	63818	41374	22444
Unadjusted period prevalence (%)
Whole population	1.13	1.36	0.73
Only index persons	1.29	1.52	0.86
Median age at first event (years)
Whole population	73.12	77.26	65.64
Only index persons	73.08	77.07	65.73

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	7270	4227	3043
Unadjusted period prevalence (%)	1.40	1.44	1.34
Median age at first event (years)	69.96	71.31	68.08

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
6435: Matched controls
64199

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

4.1

323.0

1998

6333

E87.6

ICD-10 Finland

Hypokalaemia

46.2

323.0

721

175

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

4503599627370496.0

323.0

6376

144

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

8.4

323.0

1058

1469

C03CA01

ATC

furosemide; systemic

3.0

323.0

3006

14614

R53

ICD-10 Finland

Malaise and fatigue

3.6

323.0

2144

7853

AA1AD

NOMESCO Finland

CT of head and brain

3.8

323.0

2597

9754

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.8

320.5

3557

19850

E86

ICD-10 Finland

Volume depletion

68.8

315.6

365

R56.8

ICD-10 Finland

Other and unspecified convulsions

7.6

305.0

767

1127

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.7

303.2

1590

5254

C08CA01

ATC

amlodipine; oral

2.6

279.1

3105

16841

I10

ICD-10 Finland

Essential (primary) hypertension

2.6

274.2

4495

30132

E87.5

ICD-10 Finland

Hyperkalaemia

49.6

271.2

331

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.8

268.3

2287

10526

N06AX11

ATC

mirtazapine; oral

2.6

254.8

2566

12942

N05AH04

ATC

quetiapine; oral

3.4

249.1

1417

4898

R11

ICD-10 Finland

Nausea and vomiting

4.5

245.8

964

2405

N05BA04

ATC

oxazepam; oral

2.7

236.6

2159

10180

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.5

235.6

2642

13976

C07AB07

ATC

bisoprolol; oral

2.4

233.8

3692

23266

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.6

232.2

2385

12001

D64.9

ICD-10 Finland

Anaemia, unspecified

3.6

224.0

1164

3715

N05CF01

ATC

zopiclone; oral

2.4

217.8

2757

15354

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

3.7

208.3

1041

3202

N03AG01

ATC

valproic acid; systemic, rectal

5.2

207.0

702

1488

A02BC02

ATC

pantoprazole; systemic

2.3

205.3

4481

32023

C03DA01

ATC

spironolactone; oral

3.4

204.9

1155

3904

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

3.1

198.8

1319

5002

A28

ICPC

Limited function/disability NOS

2.8

196.9

1576

6737

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

6.6

196.7

536

865

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

3.0

194.6

1363

5351

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.3

189.7

1106

3814

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

4.9

186.7

659

1453

I50.9

ICD-10 Finland

Heart failure, unspecified

2.8

184.4

1424

5924

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

9.5

180.5

388

432

G40.9

ICD-10 Finland

Epilepsy, unspecified

6.5

179.8

498

819

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.0

176.5

1155

4302

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.5

173.0

904

2852

F10.25

ICD-10 Finland

Alcohol dependence continuous use

13.5

172.8

310

240

N05BA01

ATC

diazepam; systemic, rectal

2.9

171.3

1256

5031

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

4.1

171.1

740

1987

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.4

170.5

918

2962

A06AD11

ATC

lactulose; oral

2.6

167.7

1472

6557

N05AH03

ATC

olanzapine; systemic

4.8

167.4

599

1334

N17.9

ICD-10 Finland

Acute renal failure, unspecified

6.1

167.0

486

851

H02AB09

ATC

hydrocortisone; systemic

9.9

165.4

347

369

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.7

164.6

1352

5787

N03AX14

ATC

levetiracetam; systemic

7.7

162.4

398

548

TPH04

NOMESCO Finland

Cathetrisation of vein

2.4

157.0

1594

7644

SPAT1254

SPAT

Administration of medicine

2.6

154.4

1337

5874

N07BB01

ATC

disulfiram; oral

5.9

151.3

451

812

N03AF02

ATC

oxcarbazepine; oral

6.3

147.1

413

688

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

8.7

145.8

328

393

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.6

144.6

1259

5524

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.0

143.7

2648

16490

N02BE01

ATC

paracetamol; systemic, rectal

2.4

143.2

5569

46700

L28

ICPC

Limited function/disability (L)

2.4

141.5

1407

6623

N05AA02

ATC

levomepromazine; systemic

5.1

141.0

480

1008

N06AB04

ATC

citalopram; systemic

2.3

140.5

1642

8377

P15

ICPC

Chronic alcohol abuse

7.8

140.0

339

457

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.4

137.4

1382

6534

N02AA05

ATC

oxycodone; systemic

2.5

135.9

1311

6059

R41.0

ICD-10 Finland

Disorientation, unspecified

5.3

134.5

438

874

N05CD07

ATC

temazepam; oral

2.5

134.1

1230

5530

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

15.8

131.8

220

143

T36

ICD-10 Finland

Poisoning by systemic antibiotics

5.4

131.3

417

808

F10.20

ICD-10 Finland

Alcohol dependence currently independent

9.1

130.9

287

329

A04

ICPC

Weakness/tiredness general

2.6

130.7

1108

4761

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

14.2

130.7

228

165

N30.0

ICD-10 Finland

Acute cystitis

2.5

129.4

1186

5317

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

14.3

129.2

225

162

TPH07

NOMESCO Finland

Cathetrisation of artery

2.9

128.6

866

3232

R06.0

ICD-10 Finland

Dyspnoea

2.1

128.4

1812

9996

F10.24

ICD-10 Finland

Alcohol depence active use

13.1

128.1

232

183

N05AX08

ATC

risperidone; systemic

3.1

127.3

796

2823

C08CA13

ATC

lercanidipine; oral

2.5

126.6

1164

5219

R42

ICD-10 Finland

Dizziness and giddiness

2.1

125.6

1724

9379

R55

ICD-10 Finland

Syncope and collapse

2.7

124.4

978

4012

WX892

NOMESCO Finland

Monitored bed care

3.3

124.0

680

2194

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.0

120.6

2243

13757

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

20.1

120.3

184

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.4

119.9

1189

5534

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

10.2

119.4

244

246

R33

ICD-10 Finland

Retention of urine

3.1

118.3

728

2547

XF400

NOMESCO Finland

ECG with 12 standard connections

2.3

117.9

1293

6320

N03AX16

ATC

pregabalin; oral

2.1

117.6

1666

9142

F05.9

ICD-10 Finland

Delirium, unspecified

6.8

116.8

307

466

JN3AD

NOMESCO Finland

Abdominal CT examination

3.2

113.8

652

2167

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.1

112.5

1653

9182

205

Kela drug reimbursment

Chronic hypertension

1.9

112.4

2228

13897

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

7.0

111.7

290

432

J01DB01

ATC

cefalexin; oral

1.9

110.7

5015

41368

SPAT1263

SPAT

Sampling

1.8

108.7

2767

18774

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

7.2

108.6

276

399

SPAT1262

SPAT

Handing over of treatment supplies

2.2

108.5

1332

6830

N05BA06

ATC

lorazepam; systemic, sublingual

3.5

108.2

547

1651

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

6.1

108.0

308

521

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.1

107.5

1484

8005

F10.09

ICD-10 Finland

Alcohol intoxication UNS

8.0

106.9

252

325

N03AF01

ATC

carbamazepine; oral, rectal

3.5

106.1

532

1594

B01AC04

ATC

clopidogrel; oral

2.3

105.2

1091

5158

C09AA05

ATC

ramipril; oral

2.0

104.6

1826

10801

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

3.0

104.3

661

2350

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

269.5

104.0

106

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

12.8

102.0

186

149

N06AX16

ATC

venlafaxine; oral

2.6

100.3

853

3624

H02AB06

ATC

prednisolone; systemic

1.8

100.1

3006

21311

R60.0

ICD-10 Finland

Localized oedema

2.4

99.3

920

4094

E22.2

ICD-10 Finland

Syndrome of inappropriate secretion of antidiuretic hormone

120.6

99.1

107

R63.1

ICD-10 Finland

Polydipsia

71.5

98.6

113

J01MA12

ATC

levofloxacin; systemic

2.1

97.9

1343

7183

A10AE04

ATC

insulin glargine; parenteral

2.8

97.9

683

2579

SPAT1301

SPAT

No procedures

1.8

97.7

2222

14364

I25.1

ICD-10 Finland

Atherosclerotic heart disease

2.0

97.7

1529

8632

TKC20

NOMESCO Finland

Catheterisation of bladder

2.9

96.6

652

2411

N05AF03

ATC

chlorprothixene; systemic

5.7

96.1

291

530

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.5

95.7

831

3568

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

3.1

94.8

564

1916

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

10.9

93.9

185

174

C02AC05

ATC

moxonidine; oral

3.7

93.0

439

1249

J01MA02

ATC

ciprofloxacin; systemic

1.8

92.8

2599

17883

N06AB10

ATC

escitalopram; oral

2.1

92.2

1159

5954

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

3.2

92.0

534

1782

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

7.5

91.8

225

308

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.9

91.3

606

2214

N02AX02

ATC

tramadol; systemic, rectal

1.7

91.0

2734

19186

F20.9

ICD-10 Finland

Schizophrenia, unspecified

6.8

90.8

239

363

N03AX09

ATC

lamotrigine; oral

4.5

90.2

340

788

S06.0

ICD-10 Finland

Concussion

2.5

90.2

781

3342

R07.4

ICD-10 Finland

Chest pain, unspecified

1.9

90.1

1773

10838

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

8.6

89.7

202

242

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.9

89.6

1530

8879

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.5

89.5

444

1315

K59.09

ICD-10 Finland

Constipation, unspecified

3.1

88.3

538

1855

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

3.4

87.7

464

1445

G72.8

ICD-10 Finland

Other specified myopathies

7.3

87.4

218

306

UJF32

NOMESCO Finland

Coloscopy

1.9

87.4

1769

10898

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.6

87.0

702

2884

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

3.6

86.2

421

1231

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

13.4

86.0

153

116

A03FA01

ATC

metoclopramide; systemic, rectal

1.9

85.5

1447

8348

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.0

85.2

1298

7191

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

3.5

84.7

427

1280

SPAT1229

SPAT

Assessment of need for aid

2.5

84.4

728

3100

I50.0

ICD-10 Finland

Congestive heart failure

2.6

84.3

679

2782

C07AA05

ATC

propranolol; systemic

2.0

84.1

1188

6384

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.1

83.4

1105

5779

E0000UV

ATC

1.7

83.1

2413

16616

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.0

82.6

1203

6537

N05BA02

ATC

chlordiazepoxide; systemic

5.0

82.3

280

583

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.2

81.8

469

1546

103

Kela drug reimbursment

Diabetes, insulin-treated

1.8

81.8

1769

11096

C07AB02

ATC

metoprolol; systemic

1.9

81.1

1585

9598

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.8

80.9

1922

12418

A06AC01

ATC

ispaghula (psylla seeds); oral

1.8

80.6

1712

10662

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.7

80.6

602

2359

E87.2

ICD-10 Finland

Acidosis

796.3

80.5

A41.9

ICD-10 Finland

Sepsis, unspecified

3.9

79.9

351

937

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.4

79.9

789

3598

P16

ICPC

Acute alcohol abuse

9.0

79.7

174

198

F29

ICD-10 Finland

Unspecified nonorganic psychosis

4.9

79.4

272

570

SPAT1216

SPAT

Assessment of functional ability

2.0

79.4

1246

6958

R03BB04

ATC

tiotropium bromide; inhalant

2.4

79.4

776

3521

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.4

78.9

727

3201

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.9

78.8

1362

7886

A46

ICD-10 Finland

Erysipelas

2.1

78.5

1024

5306

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.6

77.6

632

2600

X59

ICD-10 Finland

Exposure to unspecified factor

2.0

77.1

1177

6494

R50.9

ICD-10 Finland

Fever, unspecified

2.2

76.8

928

4647

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.8

76.8

1623

10065

N06AX21

ATC

duloxetine; oral

2.4

76.6

709

3125

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

12.0

76.5

143

121

R51.80

ICD-10 Finland

Headache

2.2

76.0

852

4125

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.3

75.7

761

3497

EBA15

NOMESCO Finland

Extraction of large number of teeth

3.8

75.6

339

921

C10AA01

ATC

simvastatin; oral

1.6

75.2

2815

20641

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.2

75.2

434

1437

K70.1

ICD-10 Finland

Alcoholic hepatitis

15.5

74.7

125

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

2.6

74.4

579

2321

A02BC01

ATC

omeprazole; systemic

1.7

73.9

1874

12279

N03AX12

ATC

gabapentin; oral

2.0

72.4

1004

5321

ZX120

NOMESCO Finland

Intravenous

2.4

72.3

674

2976

E87.8

ICD-10 Finland

Other disorders of electrolyte and fluid balance, not elsewhere classified

75.4

72.2

A02BC05

ATC

esomeprazole; systemic

1.6

71.3

2503

17956

W19

ICD-10 Finland

Unspecified fall

2.3

70.8

711

3259

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.6

70.6

552

2213

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

14.8

70.6

120

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.7

70.5

1930

12902

N06AB06

ATC

sertraline; oral

2.4

70.4

652

2870

C01DA14

ATC

isosorbide mononitrate; oral

1.9

70.1

1162

6589

N30.9

ICD-10 Finland

Cystitis, unspecified

2.8

70.0

492

1852

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

8.1

69.8

162

204

SPAT1234

SPAT

Support of social functional capacity

2.8

69.6

497

1890

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

3.9

69.5

300

788

C03AA03

ATC

hydrochlorothiazide; oral

2.2

69.3

798

3898

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.5

68.9

597

2535

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.9

68.7

1287

7619

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.7

68.6

513

2005

S01.0

ICD-10 Finland

Open wound of scalp

2.5

68.3

585

2469

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

2.0

68.3

1050

5784

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.3

68.2

681

3111

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.8

68.1

465

1720

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

6.1

67.9

192

321

T90

ICPC

Diabetes non-insulin dependent

1.8

67.7

1433

8825

2761A

ICD-9 Finland

Disorders of fluid, electrolyte and acid-base balance, Hyposmolality and/or hyponatraemia

+∞

66.7

J45.9

ICD-10 Finland

Asthma, unspecified

1.9

65.5

1141

6566

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.5

65.1

325

964

M54.5

ICD-10 Finland

Low back pain

1.7

64.5

1868

12621

N05AX12

ATC

aripiprazole; systemic

4.7

64.4

231

508

WX882

NOMESCO Finland

High dependency care

4.1

64.4

267

676

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

64.4

2254

16031

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.7

64.1

1924

13124

S97

ICPC

Chronic ulcer skin

2.8

63.7

452

1711

K92.1

ICD-10 Finland

Melaena

2.8

63.1

443

1662

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.3

63.1

670

3147

K92.0

ICD-10 Finland

Haematemesis

4.3

62.9

248

599

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

62.8

2348

16953

SPAT1167

SPAT

Insertion of urinary catheter

3.4

62.8

325

991

N04AA02

ATC

biperiden; systemic

5.0

62.1

209

430

SPAT1240

SPAT

Therapeutic discussion

2.4

62.1

554

2385

JN4BD

NOMESCO Finland

Extensive body CT

2.1

61.8

795

4060

T89

ICPC

Diabetes insulin dependent

4.1

61.2

253

639

J01EA01

ATC

trimethoprim; systemic

1.7

61.1

1742

11680

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.4

61.1

545

2344

N05AB03

ATC

perphenazine; systemic, rectal

3.6

61.0

294

847

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.1

60.8

737

3669

N03AX18

ATC

lacosamide; systemic

12.4

60.4

111

N05AH02

ATC

clozapine; systemic

6.4

60.4

165

264

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

5.1

60.3

197

392

WX872

NOMESCO Finland

Intensive care

3.1

59.5

357

1209

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

59.3

1567

10265

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

5.1

59.1

193

384

N05BA12

ATC

alprazolam; oral

2.2

59.0

688

3366

A10AE05

ATC

insulin detemir; parenteral

3.0

58.6

367

1281

N06AX03

ATC

mianserin; oral

2.8

58.6

395

1446

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

2.4

58.5

535

2330

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.8

58.3

1105

6520

JN4AD

NOMESCO Finland

Body CT examination

2.4

58.2

557

2484

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.5

58.2

493

2064

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

3.0

57.8

359

1246

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

4.2

57.7

231

567

C09AA02

ATC

enalapril; systemic

1.7

57.5

1410

9023

S18

ICPC

Laceration/cut

1.6

57.3

2544

19031

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

5.3

57.1

180

344

E27.1

ICD-10 Finland

Primary adrenocortical insufficiency

29.9

57.1

C08CA02

ATC

felodipine; oral

2.1

56.7

739

3786

J01CA08

ATC

pivmecillinam; oral

1.6

56.7

2461

18300

N06AA09

ATC

amitriptyline; systemic

2.1

56.6

707

3557

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.9

56.6

374

1352

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.6

56.5

1861

12919

C10AA05

ATC

atorvastatin; oral

1.6

56.4

2222

16131

C09CA01

ATC

losartan; oral

1.7

56.3

1585

10543

XF600

NOMESCO Finland

Bloodpressure measurement

2.6

56.3

452

1833

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.6

56.1

2371

17502

Z71.8

ICD-10 Finland

Other specified counselling

1.7

55.9

1274

7968

WX730

NOMESCO Finland

Conventional respirator

5.5

55.9

171

316

E83.51

ICD-10 Finland

Hypocalcemia

55.4

55.6

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.2

55.6

643

3128

M79.6

ICD-10 Finland

Pain in limb

1.6

55.4

2060

14729

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.6

55.3

1652

11159

J01FF01

ATC

clindamycin; systemic

1.7

55.2

1577

10522

WZC30

NOMESCO Finland

Teaching

2.0

55.1

820

4431

WX110

NOMESCO Finland

Local anesthesy

1.5

54.8

3712

30439

P29

ICPC

Psychological sympt/compl other

3.2

54.7

305

982

NA1AD

NOMESCO Finland

Cervical spine CT examination

3.2

54.5

311

1018

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.6

54.0

412

1625

SPAT1260

SPAT

Consultation of another employee

1.8

53.8

1152

7055

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

3.5

53.7

262

763

N06AB03

ATC

fluoxetine; oral

2.0

53.5

760

4030

P72

ICPC

Schizophrenia

5.5

53.2

163

302

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.9

53.1

959

5548

S42.2

ICD-10 Finland

Fracture of upper end of humerus

2.6

53.1

406

1602

Z51.5

ICD-10 Finland

Palliative care

2.4

53.0

482

2091

R03AC02

ATC

salbutamol; inhalant

1.5

52.7

2903

22663

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

2.1

52.6

637

3160

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

52.4

1258

7969

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.7

52.2

1473

9768

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.8

51.9

355

1310

WW500

NOMESCO Finland

Blood transfusion

3.0

51.8

323

1124

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

6.7

51.7

136

207

TK800

NOMESCO Finland

Hemodialysis

4.9

51.6

176

368

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

51.2

2683

20673

AN1

Coronary angiography

2.0

51.1

722

3815

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.0

51.0

695

3618

N05BE01

ATC

buspirone; oral

3.7

51.0

236

658

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.9

50.6

867

4920

B01AB05

ATC

enoxaparin; parenteral

1.6

50.5

1892

13483

K70.4

ICD-10 Finland

Alcoholic hepatic failure

19.4

50.4

A29

ICPC

General symptom/complaint other

2.0

50.3

752

4059

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

4.2

50.2

201

493

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.6

50.2

386

1528

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.2

50.0

549

2606

N05AD01

ATC

haloperidol; systemic

3.1

50.0

288

950

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.7

49.8

365

1405

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

3.4

49.7

255

772

N03AE01

ATC

clonazepam; systemic

2.5

49.6

418

1741

K59.0

ICD-10 Finland

Constipation

2.4

49.4

440

1886

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.2

49.4

521

2429

A10BA02

ATC

metformin; oral

1.6

49.3

1673

11615

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.4

49.3

251

756

V03AA01

ATC

5.0

49.2

163

330

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

3.3

49.2

262

816

R18

ICD-10 Finland

Ascites

4.4

48.5

184

429

UKC02

NOMESCO Finland

Cystoscopy

1.8

48.2

1042

6379

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

9.6

48.2

100

105

SPAT1310

SPAT

Counselling related to known health issue

1.6

48.1

1872

13429

Z72.1

ICD-10 Finland

Alcohol use

6.7

48.0

125

188

R02

ICPC

Shortness of breath/dyspnoea

1.9

48.0

757

4167

SPAT1100

SPAT

Long-term monitoring of blood pressure

2.2

48.0

547

2641

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

24.5

47.9

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.3

47.7

456

2024

J01MA14

ATC

moxifloxacin; systemic

2.1

47.6

565

2775

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

3.1

47.2

278

930

E000001

ATC

1.7

47.0

1176

7514

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.7

46.9

1029

6318

R4110

NOMESCO Finland

Physiotherapy

1.6

46.6

1537

10568

SPAT1255

SPAT

Intravenous administration of medicine

2.3

46.6

456

2047

I95.1

ICD-10 Finland

Orthostatic hypotension

3.0

46.5

291

1014

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.2

46.2

520

2491

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

4.6

46.0

164

360

A01

ICPC

Pain general/multiple sites

2.2

45.9

523

2520

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.9

45.8

723

3976

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.8

45.7

859

5016

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.9

45.6

740

4108

H02AA02

ATC

fludrocortisone; oral

7.4

45.5

111

152

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.9

45.5

286

1001

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.7

45.3

1122

7139

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

11.9

45.2

P01

ICPC

Feeling anxious/nervous/tense

2.4

45.2

407

1752

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

3.1

45.1

260

858

N06AA12

ATC

doxepin; systemic

2.4

44.8

418

1833

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

6.2

44.8

124

203

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.2

44.7

507

2437

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

3.0

44.3

269

920

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

44.3

2500

19372

E23.00

ICD-10 Finland

Panhypopituitarism

14.2

44.3

183

Kela drug reimbursment

Lamotrigin and topiramate

7.5

44.2

107

145

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

44.0

1959

14426

F51.0

ICD-10 Finland

Nonorganic insomnia

1.9

43.9

658

3547

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

4.1

43.6

177

441

F10.41

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol with seizures

22.6

43.4

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

10.5

43.4

P99

ICPC

Psychological disorders other

4.3

43.3

168

401

EBA00

NOMESCO Finland

Extraction of tooth

1.5

43.1

1717

12315

N05AA01

ATC

chlorpromazine; systemic, rectal

5.5

43.1

131

241

N19

ICD-10 Finland

Unspecified kidney failure

3.1

43.1

253

845

P03

ICPC

Feeling depressed

2.4

42.8

386

1663

A09AA02

ATC

multienzymes (lipase, protease etc.)

3.9

42.6

184

484

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.0

42.6

629

3369

N05AF05

ATC

zuclopenthixol; systemic

6.3

42.6

116

186

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

5.5

42.5

129

237

U05

ICPC

Urination problems other

2.5

42.4

345

1409

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.9

42.3

662

3621

I95.9

ICD-10 Finland

Hypotension, unspecified

4.8

42.1

144

303

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

2.3

42.0

406

1811

R60.9

ICD-10 Finland

Oedema, unspecified

2.5

41.9

344

1411

G40

ICD-10 Finland

Epilepsy

7.0

41.7

105

151

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

3.6

41.6

196

555

A02BC03

ATC

lansoprazole; oral

1.5

41.6

1777

12928

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

4.1

41.6

167

412

K85

ICPC

Elevated blood pressure

1.7

41.5

1010

6372

Z94.0

ICD-10 Finland

Kidney transplant status

7.0

41.2

104

150

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.3

41.2

214

655

D07AC01

ATC

betamethasone; topical

1.5

41.1

1945

14458

C07AG02

ATC

carvedilol; oral

2.2

41.0

434

2022

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.9

40.9

610

3276

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.3

40.8

216

670

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.9

40.8

624

3382

K08.3

ICD-10 Finland

Retained dental root

2.2

40.7

442

2082

G41.9

ICD-10 Finland

Status epilepticus, unspecified

8.4

40.7

109

NF1AA

NOMESCO Finland

Hip X-ray examination

1.9

40.7

627

3407

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

10.3

40.7

A11CC03

ATC

alfacalcidol; systemic

4.2

40.7

160

387

I25.2

ICD-10 Finland

Old myocardial infarction

2.3

40.7

414

1892

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.6

40.5

319

1279

SPAT1252

SPAT

Overall medication plan or its review

2.1

40.4

516

2605

H01BA02

ATC

desmopressin; nasal, systemic, sublingual

4.7

40.4

141

303

H03AA01

ATC

levothyroxine sodium; systemic

1.6

40.3

1381

9534

SPAT1097

SPAT

Recording of ECG

1.7

40.3

961

6023

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

5.6

40.3

121

220

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

2.3

40.2

385

1707

N05AC02

ATC

thioridazine; oral

3.9

40.1

173

455

N06AB05

ATC

paroxetine; oral

2.4

40.1

352

1496

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.9

40.1

665

3712

F34.1

ICD-10 Finland

Dysthymia

3.4

40.1

204

615

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

3.1

39.9

235

786

127

Kela drug reimbursment

Transplant complication

5.4

39.7

123

232

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.7

39.6

834

5036

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.7

39.6

987

6262

F10.03

ICD-10 Finland

Alcohol-related acute intoxication with delirium

15.6

39.4

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.9

39.3

254

904

B03XA02

ATC

darbepoetin alfa; parenteral

4.4

39.3

148

344

R06AE07

ATC

cetirizine; oral

1.4

39.2

2289

17725

SPAT1104

SPAT

Monitoring of emergency patient

2.1

39.1

457

2224

N17.8

ICD-10 Finland

Other acute renal failure

6.3

39.1

107

173

A10BH01

ATC

sitagliptin; oral

2.0

39.1

560

2962

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.6

39.0

1401

9767

N18.8

ICD-10 Finland

Other chronic renal failure

3.4

38.8

198

598

N05CF02

ATC

zolpidem; oral

1.7

38.7

977

6218

N05AB01

ATC

dixyrazine; systemic

4.8

38.7

132

277

XX3DW

NOMESCO Finland

Time consuming IT work

1.9

38.7

622

3429

U07

ICPC

Urine symptom/complaint other

2.2

38.5

399

1838

SPAT1265

SPAT

Breathalyser

7.2

38.2

131

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

7.9

38.0

112

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

4.1

37.9

151

370

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.8

37.4

258

957

C09CA03

ATC

valsartan; oral

1.9

37.2

576

3131

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

2.1

37.1

430

2084

M80.9

ICD-10 Finland

Unspecified osteoporosis with pathological fracture

3.3

37.0

191

582

K07

ICPC

Swollen ankles/oedema

2.4

37.0

337

1459

101

Kela drug reimbursment

Anterior pituitary hypofunction

9.9

37.0

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.8

36.9

753

4495

J01DA01

ATC

[U] cefalexin; systemic

1.4

36.9

3584

30368

R40.2

ICD-10 Finland

Coma, unspecified

6.1

36.8

102

168

K59.1

ICD-10 Finland

Functional diarrhoea

2.4

36.6

337

1466

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

36.6

696

4064

XF404

NOMESCO Finland

Ambulatory ECG

1.9

36.4

558

3024

M05BX04

ATC

denosumab; parenteral

2.2

36.2

399

1891

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

36.1

2502

19921

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

4.4

36.0

134

308

WX002

NOMESCO Finland

Sedation and analgesia

1.6

35.5

1174

8000

188

Kela drug reimbursment

Psychosis requiring demanding treatment

6.1

35.4

161

K86.1

ICD-10 Finland

Other chronic pancreatitis

6.1

35.4

165

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

3.3

35.4

189

591

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.6

35.4

1132

7652

F60.9

ICD-10 Finland

Personality disorder, unspecified

6.6

35.4

143

K70.0

ICD-10 Finland

Alcoholic fatty liver

8.0

35.3

102

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

3.6

35.2

167

477

F61.0

ICD-10 Finland

Mixed personality disorders

5.1

35.2

114

227

D09

ICPC

Nausea

2.8

35.1

230

827

K02.1

ICD-10 Finland

Caries of dentine

1.4

35.0

2732

22182

F41.1

ICD-10 Finland

Generalized anxiety disorder

3.1

34.9

204

681

N06AX05

ATC

trazodone; oral

3.5

34.9

169

491

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.1

34.8

408

1987

L04AA06

ATC

mycophenolic acid; systemic

4.7

34.8

122

264

F05.8

ICD-10 Finland

Other delirium

6.9

34.8

128

N06AX26

ATC

vortioxetine; oral

2.6

34.8

270

1072

105

Kela drug reimbursment

Adrenal cortical hypofunction

18.1

34.7

V03AE01

ATC

polystyrene sulfonate; oral

5.4

34.7

106

197

M05BA04

ATC

alendronic acid; oral

1.8

34.7

699

4152

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

2.8

34.6

239

887

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

2.1

34.5

429

2140

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.7

34.4

253

973

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

5.4

34.3

106

200

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.0

34.3

439

2219

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

7.6

34.2

107

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.1

34.1

420

2086

R52.9

ICD-10 Finland

Pain, unspecified

2.0

34.1

479

2508

B03BA03

ATC

hydroxocobalamin; parenteral

2.1

34.0

426

2133

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

4.2

33.9

132

317

X58

ICD-10 Finland

Exposure to other specified factors

1.8

33.8

690

4113

G04CA02

ATC

tamsulosin; oral

1.5

33.8

1269

8896

B01AF02

ATC

apixaban; oral

1.8

33.8

654

3834

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

4.6

33.8

121

268

SPAT1211

SPAT

Application of soft bandage

1.9

33.8

569

3186

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

33.7

952

6225

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

33.5

470

2461

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.8

33.4

607

3485

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.5

33.4

274

1121

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.6

33.4

259

1030

S22.3

ICD-10 Finland

Fracture of rib

2.1

33.4

404

1995

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

6.1

33.4

151

I20.09

ICD-10 Finland

Unstable angina

2.2

33.3

349

1616

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.2

33.3

351

1628

U08

ICPC

Urinary retention

3.7

33.1

147

398

137

Kela drug reimbursment

Uraemia requiring dialysis

7.0

33.0

120

N05BA09

ATC

clobazam; oral

10.7

33.0

B01AA03

ATC

warfarin; systemic

1.5

32.9

1336

9526

F20

ICD-10 Finland

Schizophrenia

8.2

32.7

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

6.4

32.6

137

N05AN01

ATC

lithium; oral

3.7

32.5

148

409

H25.1

ICD-10 Finland

Senile nuclear cataract

1.4

32.5

1881

14404

IGY02

NOMESCO Finland

Psychiatric monitoring contact

4.8

32.2

110

232

A12AA04

ATC

calcium carbonate; oral

4.5

32.2

117

263

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

2.7

32.1

230

874

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.1

32.0

183

601

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

7.7

32.0

B05DA

ATC

Isotonic solutions

8.4

32.0

R04.0

ICD-10 Finland

Epistaxis

2.0

31.7

458

2424

Z02.7

ICD-10 Finland

Issue of medical certificate

2.2

31.7

355

1696

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.2

31.6

332

1540

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.8

31.4

626

3700

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

4.1

31.4

127

317

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

4.8

31.2

107

227

P20

ICPC

Memory disturbance

1.6

31.0

875

5709

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

4.4

31.0

114

260

C09CA06

ATC

candesartan; oral

1.5

31.0

1183

8304

L17

ICPC

Foot/toe symptom/complaint

1.5

30.9

1382

10038

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

5.9

30.9

151

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

5.9

30.9

151

E83.4

ICD-10 Finland

Disorders of magnesium metabolism

313.6

30.8

P01AB01

ATC

metronidazole; oral, rectal

1.4

30.7

2062

16185

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

7.7

30.7

M81.9

ICD-10 Finland

Osteoporosis, unspecified

2.2

30.7

328

1532

R31

ICD-10 Finland

Unspecified haematuria

1.8

30.5

580

3373

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

4.7

30.5

105

224

N17

ICPC

Vertigo/dizziness

1.7

30.4

680

4160

P76

ICPC

Depressive disorder

2.4

30.4

271

1161

D07AA02

ATC

hydrocortisone; topical

1.7

30.4

702

4334

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

3.9

30.3

128

332

A10BH05

ATC

linagliptin; oral

2.3

30.3

300

1352

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

4.1

30.3

121

299

A02BA02

ATC

ranitidine; systemic

1.5

30.3

1242

8854

R07.3

ICD-10 Finland

Other chest pain

1.8

30.2

528

2989

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.2

30.2

339

1616

N88

ICPC

Epilepsy

8.8

30.2

SPAT1312

SPAT

General health counselling

1.4

30.1

1725

13145

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

6.0

30.1

144

Z49.2

ICD-10 Finland

Other dialysis

8.0

30.1

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.0

30.1

407

2100

A10AA01

ATC

3.2

30.1

162

511

Z49.1

ICD-10 Finland

Extracorporeal dialysis

4.9

30.0

100

206

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.8

30.0

589

3462

S72.0

ICD-10 Finland

Fracture of neck of femur

2.2

29.9

330

1565

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

6.0

29.8

142

M04AA01

ATC

allopurinol; systemic

1.6

29.8

769

4896

M48.0

ICD-10 Finland

Spinal stenosis

1.6

29.7

791

5080

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

6.4

29.7

124

K77

ICPC

Heart failure

3.0

29.7

176

591

H04AA01

ATC

glucagon; nasal, parenteral

4.0

29.7

120

300

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.5

29.6

232

929

XA400

NOMESCO Finland

EEG

7.7

29.5

XA800

NOMESCO Finland

Neuropsychological investigation

2.7

29.5

208

782

A99

ICPC

Disease/condition unspecnature/site

1.9

29.4

478

2638

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

10.2

29.3

XW000

NOMESCO Finland

Bone marrow biopsy

2.4

29.2

257

1093

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

29.2

930

6253

I50

ICD-10 Finland

Heart failure

2.4

29.1

250

1050

E23.03

ICD-10 Finland

Lack of ACTH

20.5

29.0

SPAT1307

SPAT

Psychosocial counselling and guidance

2.5

29.0

237

968

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

4.5

29.0

105

236

K90

ICPC

Stroke/cerebrovascular accident

2.8

29.0

193

701

A07AA02

ATC

nystatin; oral

1.9

28.9

424

2254

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.6

28.9

853

5625

N03AB02

ATC

phenytoin; systemic

3.9

28.8

123

323

SPAT1125

SPAT

Stoma care and guidance

3.3

28.8

149

457

L03

ICPC

Low back symptom/complaint

1.5

28.8

1271

9187

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.1

28.8

356

1771

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

12.8

28.7

E87

ICD-10 Finland

Other disorders of fluid, electrolyte and acid-base balance

80.3

28.7

Y94.0

ICD-10 Finland

Accident at home

3.2

28.7

157

502

J96.0

ICD-10 Finland

Acute respiratory failure

4.2

28.6

111

267

K56.7

ICD-10 Finland

Ileus, unspecified

3.5

28.6

138

401

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.8

28.5

185

660

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.9

28.4

416

2210

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

5.1

28.2

177

D12

ICPC

Constipation

2.5

28.1

232

954

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

4.1

28.1

113

281

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

3.0

28.1

164

548

GD1AD

NOMESCO Finland

Thorax CT examination

2.3

28.1

264

1161

Z00.8

ICD-10 Finland

Other general examinations

2.0

28.1

381

1967

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

9.4

28.0

J01CA04

ATC

amoxicillin; systemic

1.4

27.9

4406

39472

G44.2

ICD-10 Finland

Tension-type headache

1.7

27.8

647

3997

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.8

27.8

183

661

K70.9

ICD-10 Finland

Alcoholic liver disease, unspecified

11.9

27.8

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

3.1

27.8

156

508

G37.2

ICD-10 Finland

Central pontine myelinolysis

282.0

27.7

K29.7

ICD-10 Finland

Gastritis, unspecified

2.5

27.7

224

913

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

5.1

27.6

177

D35.2

ICD-10 Finland

Benign neoplasm: Pituitary gland

5.1

27.6

173

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.6

27.6

205

796

F10.4

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Withdrawal state with delirium

17.3

27.4

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

27.4

1386

10286

C09CA07

ATC

telmisartan; oral

1.9

27.3

421

2278

SPAT1053

SPAT

Memory test

1.5

27.3

1042

7291

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

2.3

27.3

270

1219

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

9.0

27.3

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

27.3

1089

7695

R13

ICD-10 Finland

Dysphagia

2.0

27.3

379

1976

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

6.2

26.9

118

F32

ICD-10 Finland

Depressive episode

2.4

26.9

239

1021

G40.10

ICD-10 Finland

Simple partial seizures

6.1

26.9

122

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.4

26.9

231

972

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

4.2

26.8

104

251

C08CA05

ATC

nifedipine; systemic

1.9

26.8

422

2302

207

Kela drug reimbursment

Chronic arrhythmias

1.5

26.7

935

6415

H02AB04

ATC

methylprednisolone; systemic

1.6

26.6

827

5513

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

26.6

1504

11388

U71

ICPC

Cystitis/urinary infection other

2.0

26.5

371

1938

C10AA04

ATC

fluvastatin; oral

1.8

26.5

515

3017

U04

ICPC

Incontinence urine

2.1

26.5

328

1631

U02

ICPC

Urinary frequency/urgency

1.6

26.5

753

4912

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.3

26.5

262

1183

R95

ICPC

Chron obstructive pulmonary disease

2.7

26.3

181

672

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.0

26.3

352

1807

102

Kela drug reimbursment

Diabetes insipidus

16.2

26.2

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

26.1

889

6057

OAB43

SPAT

0.4

26.1

123

2874

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.3

26.1

242

1057

A10BB12

ATC

glimepiride; oral

1.8

26.1

463

2633

N05CD02

ATC

nitrazepam; oral

2.9

26.1

163

571

L89

ICD-10 Finland

Decubitus ulcer and pressure area

3.2

26.0

140

443

A12BA01

ATC

potassium chloride; oral

1.9

26.0

375

1983

C09BA02

ATC

enalapril and diuretics; systemic

1.7

26.0

542

3243

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.8

26.0

489

2836

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.3

26.0

134

411

D11

ICPC

Diarrhoea

1.8

26.0

506

2964

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

25.9

806

5372

UJF30

NOMESCO Finland

Ileoscopy through colon

1.8

25.9

506

2967

R35

ICD-10 Finland

Polyuria

1.9

25.8

375

1987

J02AC01

ATC

fluconazole; systemic

1.4

25.8

1909

15134

AAE10

NOMESCO Finland

Transsphenoidal total or partial excision of intracranial lesion

8.8

25.6

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

3.2

25.6

137

432

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.0

25.5

150

505

D01

ICPC

Abdominal pain/cramps general

1.7

25.5

516

3060

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

4.1

25.5

100

244

A41.8

ICD-10 Finland

Other specified sepsis

3.5

25.4

122

354

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

3.1

25.4

145

476

K85.2

ICD-10 Finland

Alcohol-induced acute pancreatitis

8.6

25.4

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.8

25.3

172

634

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

25.3

1774

13925

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

2.6

25.3

185

714

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

4.4

25.1

210

E83.50

ICD-10 Finland

Hypercalcemia

7.6

25.1

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

5.0

25.1

162

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.8

25.1

453

2590

J01AA02

ATC

doxycycline; systemic

1.3

25.1

4504

40736

130

Kela drug reimbursment

Malignant tumour

1.7

25.1

512

3043

G40.6

ICD-10 Finland

Grand mal seizures, unspecified (with or without petit mal)

8.0

25.0

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

4.3

25.0

225

XF402

NOMESCO Finland

ECG with work load test

1.7

25.0

579

3573

Z00.0

ICD-10 Finland

General medical examination

1.5

24.9

1015

7191

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.5

24.9

901

6223

L29.9

ICD-10 Finland

Pruritus, unspecified

2.9

24.8

156

549

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.4

24.8

222

954

F10.02

ICD-10 Finland

Alcohol-related acute intoxication with other acute clinical complications

18.1

24.7

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.8

24.5

420

2361

P74

ICPC

Anxiety disorder/anxiety state

2.9

24.5

157

558

Angiography of the heart and coronary arteries

1.9

24.3

379

2061

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.9

24.3

400

2219

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

4.4

24.3

204

SPAT1172

SPAT

Guidance concerning hydration

2.5

24.2

192

775

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.4

24.2

1212

8947

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

5.2

24.2

148

V03AB30

ATC

5.3

24.1

140

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

2.1

24.1

289

1421

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

3.1

24.0

133

430

F02.89*G40.9

ICD-10 Finland

Dementia in epilepsy

15.7

24.0

H3603, E103

ICD-10 Finland

6.0

24.0

113

N07BA03

ATC

varenicline; oral

2.3

24.0

226

997

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

5.4

24.0

133

SPAT1251

SPAT

Organisation of medication

2.2

23.8

256

1200

R10.0

ICD-10 Finland

Acute abdomen

2.6

23.8

174

670

E89.00

ICD-10 Finland

Postirradiation hypothyroidism

20.6

23.8

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

23.7

1783

14125

D10

ICPC

Vomiting

2.4

23.7

215

930

A04AA01

ATC

ondansetron; systemic, rectal

1.9

23.7

366

1983

N06AA06

ATC

trimipramine; systemic

2.7

23.6

163

608

K30

ICD-10 Finland

Functional dyspepsia

1.7

23.6

533

3262

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

2.7

23.6

166

626

XCK10

NOMESCO Finland

Photography of fundus of eye

1.6

23.6

592

3731

R05

ICPC

Cough

1.4

23.5

1114

8126

A01AB09

ATC

miconazole; local oral

1.7

23.5

552

3415

D64.8

ICD-10 Finland

Other specified anaemias

3.3

23.5

123

382

Z08

ICPC

Social welfare problem

4.2

23.5

220

ZXA00

NOMESCO Finland

Right side

1.4

23.5

1587

12351

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

4.8

23.5

166

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

3.2

23.4

125

394

F10

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol

23.6

23.4

H36.00

ICD-10 Finland

Diabetic background retinopathy

4.0

23.4

240

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.6

23.4

176

691

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

2.2

23.3

242

1116

S70.0

ICD-10 Finland

Contusion of hip

2.2

23.3

239

1097

N05CD08

ATC

midazolam; nasal, systemic

2.6

23.3

171

661

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.4

23.2

200

841

Z49.0

ICD-10 Finland

Preparatory care for dialysis

5.3

23.2

134

R63.4

ICD-10 Finland

Abnormal weight loss

2.3

23.2

226

1014

ZXA05

NOMESCO Finland

Left side

1.4

23.2

1489

11484

E10

ICD-10 Finland

Type 1 diabetes mellitus

3.8

23.1

257

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

3.6

23.1

105

292

WW200

NOMESCO Finland

Immunization

2.8

23.1

155

568

H3600, E103

ICD-10 Finland

5.7

22.9

116

B01AB10

ATC

tinzaparin; parenteral

1.9

22.9

375

2073

B05DB

ATC

Hypertonic solutions

7.1

22.9

E87.3

ICD-10 Finland

Alkalosis

+∞

22.9

F10.3

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Withdrawal state

9.8

22.9

A08

ICPC

Swelling

2.1

22.9

266

1292

TPX10

NOMESCO Finland

Implantation of vascular injection port

2.6

22.8

165

632

I20.00

ICD-10 Finland

Unstable angina

2.4

22.8

193

807

SPAT1227

SPAT

Substance abuse rehabilitation

6.9

22.8

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

4.8

22.8

158

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

6.4

22.8

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

5.5

22.8

125

C09DA06

ATC

candesartan and diuretics; oral

1.8

22.7

423

2442

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

22.7

1201

8942

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

4.6

22.7

172

A05

ICPC

Feeling ill

2.1

22.7

264

1282

N06AG02

ATC

moclobemide; oral

2.1

22.6

262

1270

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

3.2

22.6

120

377

J96.1

ICD-10 Finland

Chronic respiratory failure

2.7

22.6

153

565

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

3.1

22.6

129

425

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.1

22.6

277

1376

F31

ICD-10 Finland

Bipolar affective disorder

5.1

22.6

143

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

2.8

22.5

144

513

S29

ICPC

Skin symptom/complaint other

1.5

22.5

906

6389

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

3.8

22.5

259

F20.5

ICD-10 Finland

Residual schizophrenia

6.3

22.4

F20.10

ICD-10 Finland

Raise schizophrenia continuously

9.4

22.4

N01

ICPC

Headache

1.8

22.4

391

2210

N30

ICD-10 Finland

Cystitis

1.8

22.4

393

2226

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.4

22.4

201

866

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.7

22.4

270

I25

ICD-10 Finland

Chronic ischaemic heart disease

2.1

22.3

266

1303

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

4.3

22.3

198

R05

ICD-10 Finland

Cough

1.5

22.3

992

7145

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

2.0

22.3

275

1370

F41.09

ICD-10 Finland

UNS Panic Syndrome

3.2

22.3

119

376

J01FA06

ATC

roxithromycin; oral

1.3

22.3

2184

17979

TAB00

NOMESCO Finland

Lumbar puncture

2.3

22.2

217

975

F32.1

ICD-10 Finland

Moderate depressive episode

2.3

22.2

213

946

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

4.7

22.2

163

EBA30

NOMESCO Finland

Excision of root of tooth

2.0

22.1

297

1526

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

2.8

22.1

148

541

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.9

22.1

338

1826

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.0

22.1

310

1623

P06

ICPC

Sleep disturbance

1.7

22.0

446

2641

P28

ICPC

Limited function/disability (P)

5.6

22.0

114

K05.31

ICD-10 Finland

Periodontitis pronounced

1.7

22.0

511

3149

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

3.4

22.0

107

315

UJD02

NOMESCO Finland

Gastroscopy

2.0

22.0

288

1468

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

3.2

22.0

118

374

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

9.8

21.9

K72.9

ICD-10 Finland

Hepatic failure, unspecified

7.6

21.9

U01

ICPC

Dysuria/painful urination

1.8

21.9

405

2332

AA400

NOMESCO Finland

Electroconvulsive therapy

5.7

21.9

111

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

5.4

21.9

123

N05AL01

ATC

sulpiride; systemic

3.2

21.9

119

381

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.8

21.8

143

517

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

3.2

21.8

115

360

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.4

21.8

195

840

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

4.7

21.8

162

P18

ICPC

Medication abuse

8.3

21.7

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

2.9

21.7

132

456

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.4

21.7

190

808

C09DA01

ATC

losartan and diuretics; oral

1.6

21.6

606

3928

XKD00

NOMESCO Finland

Uroflowmetry

1.5

21.6

873

6158

RS222

NOMESCO Finland

3.7

21.6

258

R4190

NOMESCO Finland

Nutritional therapy

2.6

21.6

160

621

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.2

21.6

225

1042

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

4.7

21.5

155

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.9

21.5

342

1871

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

5.8

21.4

106

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

3.5

21.4

103

301

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

6.6

21.3

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.8

21.3

354

1968

L04AD01

ATC

ciclosporin; systemic

3.3

21.3

109

334

JAH00

NOMESCO Finland

Laparotomy

2.5

21.3

173

709

NFB20

NOMESCO Finland

Primary partial prosthetic replacement of hip joint using cement, other or unspecified

2.3

21.3

196

855

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.7

21.3

474

2887

A10AE06

ATC

insulin degludec; parenteral

2.9

21.3

134

473

WVA20

NOMESCO Finland

Medicine administration

2.9

21.3

134

473

J45

ICD-10 Finland

Asthma

1.7

21.2

484

2969

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.2

21.2

223

1037

U13

ICPC

Bladder symptom/complaint other

2.3

21.2

191

826

K76.7

ICD-10 Finland

Hepatorenal syndrome

18.9

21.2

177

Kela drug reimbursment

Insulin glargine 300 U / ml

3.4

21.1

105

315

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

2.4

21.1

177

735

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

3.0

21.1

121

401

ZZA00

NOMESCO Finland

Split skin graft

2.3

21.0

197

865

B81

ICPC

Anaemia vit B12/folate deficiency

2.1

21.0

250

1227

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

8.4

21.0

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.6

21.0

641

4242

WX290

NOMESCO Finland

Other blockade of nerve

1.3

21.0

1802

14520

N06AX12

ATC

bupropion; oral

2.2

20.9

213

975

N05AF01

ATC

flupentixol; systemic

3.1

20.9

117

382

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

2.1

20.9

237

1136

K85

ICD-10 Finland

Acute pancreatitis

3.0

20.9

124

422

A03FA02

ATC

cisapride; oral, rectal

1.7

20.9

498

3093

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.9

20.8

315

1693

L76

ICPC

Fracture: other

2.3

20.8

197

873

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

4.3

20.8

184

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.9

20.8

299

1581

R96

ICPC

Asthma

1.7

20.7

466

2848

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.2

20.6

205

928

E87.7

ICD-10 Finland

Fluid overload

210.1

20.6

SPAT1325

SPAT

Vaccination

1.3

20.5

1998

16380

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

4.4

20.5

168

R03BA05

ATC

fluticasone; inhalant

1.5

20.5

884

6317

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

6.0

20.4

S82.6

ICD-10 Finland

Fracture of lateral malleolus

1.9

20.4

324

1774

JDB10

NOMESCO Finland

Percutaneous gastrostomy

3.5

20.4

271

A03CA02

ATC

clidinium and psycholeptics; oral

1.7

20.3

398

2335

R39.1

ICD-10 Finland

Other difficulties with micturition

2.4

20.3

178

757

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

3.5

20.3

272

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.7

20.3

138

512

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.7

20.1

136

501

F41.8

ICD-10 Finland

Other specified anxiety disorders

3.5

20.1

264

E66.00

ICD-10 Finland

Metabolic syndrome

2.1

20.1

219

1035

A10AA02

ATC

2.2

20.0

204

934

F10.01

ICD-10 Finland

Alcohol-related acute intoxication with permanent or other somatic damage

6.2

20.0

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.1

20.0

109

350

B82

ICPC

Anaemia other/unspecified

2.5

20.0

154

612

IGY99

NOMESCO Finland

Other psychiatric treatment contact

4.3

20.0

177

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.5

20.0

159

646

SPAT1281

SPAT

Other administrative function

1.7

19.9

428

2579

J94.8

ICD-10 Finland

Other specified pleural conditions

2.9

19.8

121

419

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

6.6

19.8

F20.0

ICD-10 Finland

Paranoid schizophrenia

5.5

19.8

105

Z29

ICPC

Social problem NOS

3.0

19.8

115

386

G62.1

ICD-10 Finland

Alcoholic polyneuropathy

8.8

19.7

R32

ICD-10 Finland

Unspecified urinary incontinence

2.3

19.7

187

830

N18

ICPC

Paralysis/weakness

2.9

19.7

124

436

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

4.8

19.7

135

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.8

19.7

325

1805

Z71.4

ICD-10 Finland

Alcohol abuse counselling and surveillance

7.3

19.6

N03AX11

ATC

topiramate; oral

3.0

19.6

113

377

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.6

19.6

145

565

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.4

19.5

167

702

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.1

19.5

220

1055

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

3.9

19.5

210

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.6

19.5

144

559

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.5

19.5

652

4406

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

19.5

3010

26195

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.1

19.5

107

346

WX402

NOMESCO Finland

General anaesthesia

1.5

19.5

736

5114

SPAT1139

SPAT

Nutrition survey

2.2

19.4

200

921

W10

ICD-10 Finland

Fall on and from stairs and steps

1.9

19.4

280

1480

J01CF05

ATC

flucloxacillin; systemic

2.2

19.4

207

968

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

4.4

19.4

164

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

3.9

19.3

207

L04AX01

ATC

azathioprine; systemic

2.1

19.3

221

1067

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.6

19.3

563

3685

NHQ40

NOMESCO Finland

Amputation of toe

3.0

19.2

111

371

SPAT1101

SPAT

Orthostatic test

1.8

19.2

325

1820

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

2.4

19.1

160

667

JFF10

NOMESCO Finland

Loop enterostomy

6.2

19.1

TK820

NOMESCO Finland

Peritoneal dialysis

8.0

19.1

Z72.0

ICD-10 Finland

Tobacco use

2.8

19.1

121

429

H02AB07

ATC

prednisone; oral

1.5

19.1

781

5515

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.3

19.1

2502

21302

IAB10

NOMESCO Finland

Psychiatric consultation concerning substance abuse

26.0

19.1

J01MA06

ATC

norfloxacin; oral

1.5

19.1

797

5654

S76

ICPC

Skin infection other

1.9

19.0

275

1455

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

2.8

19.0

122

437

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.3

19.0

173

752

F10.06

ICD-10 Finland

Alcohol-related acute intoxication with seizures

20.0

19.0

S42.0

ICD-10 Finland

Fracture of clavicle

2.4

19.0

161

676

S22.4

ICD-10 Finland

Multiple fractures of ribs

2.7

18.9

129

479

SPAT1304

SPAT

Counselling and guidance related to ageing

1.6

18.9

483

3055

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.5

18.9

151

614

F10.52

ICD-10 Finland

Psychotic alcohol hallucination

11.3

18.9

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

6.3

18.8

N03AX22

ATC

perampanel; oral

34.3

18.8

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.6

18.8

479

3025

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

3.6

18.8

237

T74.1

ICD-10 Finland

Physical abuse

4.1

18.8

183

I50.1

ICD-10 Finland

Left ventricular failure

1.9

18.8

277

1478

N06AB08

ATC

fluvoxamine; oral

2.4

18.8

159

665

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.4

18.7

165

704

A69

ICPC

General and Unspecified, Other reason for encounter NEC

2.4

18.7

162

685

J46

ICD-10 Finland

Status asthmaticus

2.4

18.7

165

706

F20.39

ICD-10 Finland

Undifferentiated schizophrenia UNS

6.7

18.7

G40.89

ICD-10 Finland

Other epilepsy

7.2

18.7

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

2.7

18.6

125

461

A07AA09

ATC

vancomycin; oral

3.4

18.6

265

SPAT1153

SPAT

Removal of sutures

1.3

18.6

1775

14466

SPAT1247

SPAT

Outpatient detoxication and monitoring

6.9

18.6

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

6.3

18.6

R06.2

ICD-10 Finland

Wheezing

2.1

18.5

218

1066

K29.2

ICD-10 Finland

Alcoholic gastritis

9.8

18.5

E27.2

ICD-10 Finland

Addisonian crisis

38.4

18.5

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.0

18.5

250

1293

TQW80

NOMESCO Finland

Local dermatologic skincare

2.4

18.4

154

640

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

6.4

18.4

F20.3

ICD-10 Finland

Undifferentiated schizophrenia

6.4

18.4

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.7

18.4

385

2301

J20

ICD-10 Finland

Acute bronchitis

1.6

18.4

475

3013

L95

ICPC

Osteoporosis

2.1

18.4

219

1075

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.3

18.4

171

750

2951C

ICD-9 Finland

Schizophrenic psychoses, Disorganised type[HEBEFREENISTYYPPINEN SKITSOFRENIA,KROONINEN]

15.0

18.4

WX302

NOMESCO Finland

Thoracal epidural anesthesy

1.9

18.3

273

1459

D07AB08

ATC

desonide; topical

1.6

18.3

543

3563

ZXA10

NOMESCO Finland

Bilateral

1.4

18.2

1069

8072

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

3.1

18.2

318

F03

ICD-10 Finland

Unspecified dementia

1.8

18.2

314

1768

F61

ICD-10 Finland

Mixed and other personality disorders

7.1

18.2

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.8

18.2

295

1626

R52.2

ICD-10 Finland

Other chronic pain

2.3

18.2

175

781

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

5.3

18.2

104

R00.1

ICD-10 Finland

Bradycardia, unspecified

2.1

18.1

212

1032

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.3

18.1

2127

17816

WX704

NOMESCO Finland

Intubation

1.8

18.1

341

1977

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

3.2

18.1

298

R4120

NOMESCO Finland

Occupational therapy

1.8

18.1

300

1667

-1

NOMESCO Finland

1.3

18.1

1453

11544

K56.0

ICD-10 Finland

Paralytic ileus

3.8

18.1

205

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

9.3

18.0

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.5

18.0

148

609

U29

ICPC

Urinary symptom/complaint other

2.3

18.0

175

787

N29

ICPC

Neurological sympt/complt other

2.7

18.0

120

441

S21

ICPC

Skin texture symptom/complaint

1.5

18.0

640

4385

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.6

18.0

467

2967

G40.09

ICD-10 Finland

Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset

6.7

17.9

K22.6

ICD-10 Finland

Gastro-oesophageal laceration-haemorrhage syndrome

5.1

17.9

110

S00.0

ICD-10 Finland

Superficial injury of scalp

2.6

17.9

135

533

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

2.7

17.9

123

460

NB6AA

NOMESCO Finland

Humerus X-ray examination

2.6

17.9

128

491

C03BA11

ATC

indapamide; oral

2.1

17.9

196

929

A02BA03

ATC

famotidine; systemic

1.9

17.8

259

1375

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

9.0

17.8

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

2.2

17.8

176

798

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

17.8

3405

30274

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.6

17.7

544

3600

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

2.9

17.7

108

374

N28

ICPC

Limited function/disability (N)

2.9

17.7

109

381

D07AC13

ATC

mometasone; topical

1.3

17.7

1464

11676

XF602

NOMESCO Finland

Bloodpressure monitoring

4.0

17.6

175

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

2.0

17.6

237

1223

N39.9

ICD-10 Finland

Disorder of urinary system, unspecified

2.7

17.6

122

459

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.7

17.6

357

2117

K86.3

ICD-10 Finland

Pseudocyst of pancreas

5.9

17.6

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

2.5

17.5

143

589

H26.4

ICD-10 Finland

After-cataract

1.5

17.5

626

4293

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

4.2

17.5

162

K20

ICD-10 Finland

Oesophagitis

2.9

17.5

104

356

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.1

17.5

198

953

SPAT1243

SPAT

Psychiatric/psychological examination

3.0

17.5

100

332

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

17.4

869

6372

OAA67

SPAT

0.3

17.4

1296

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.4

17.4

145

604

F10.22

ICD-10 Finland

Alcohol dependence is currently on clinically controlled discontinuation medication

10.7

17.4

E000003

ATC

2.0

17.3

229

1174

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

6.8

17.3

D70.82

ICD-10 Finland

Drug-induced neutropenia

3.1

17.3

327

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.8

17.3

297

1668

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.7

17.3

404

2492

N06AX22

ATC

agomelatine; oral

3.2

17.3

281

R60.1

ICD-10 Finland

Generalized oedema

5.6

17.2

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

7.2

17.2

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.5

17.1

136

551

R12

ICD-10 Finland

Heartburn

1.7

17.1

349

2073

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

8.4

17.1

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

17.1

2229

18888

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

1.9

17.1

241

1267

PA7CD

NOMESCO Finland

CT angiography of neck and brain, extensive

3.7

17.0

201

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

2.0

16.9

221

1126

T90.5

ICD-10 Finland

Sequelae of intracranial injury

3.9

16.9

182

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.1

16.9

196

953

WZA90

NOMESCO Finland

Other doctors statement

1.4

16.8

1045

7958

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

5.7

16.8

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

4.3

16.7

146

SPAT1360

SPAT

Extensive global examination

1.6

16.7

430

2724

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1489

5289

3.27

321.89

11.4

6.7

116.9

120.3

g/l

7.65

1449

5089

(3018418) pH of Serum or Plasma

3265

17518

2.56

321.58

6.1

3.5

7.4

0.12

872

3295

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3777

21766

2.52

318.00

3.8

2.6

192.7

142.7

ug/l

7.31

3418

19646

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1460

5217

3.24

311.68

2.8

2.1

0.2

g/l

9.57

1326

4849

(3031040) Bacteria [#/volume] in Urine by Automated count

5563

38800

2.83

308.37

8.3

4.7

998.8

2567.3

e6/l

1.79

507

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1123

3086

4.11

307.65

8.8

6.4

24.5

25.0

mmol/l

2.60

1106

3056

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

5058

29759

3.28

307.65

9.1

5.8

12.1

11.9

umol/l

0.20

4824

28081

(3024561) Albumin [Mass/volume] in Serum or Plasma

4548

25520

3.07

307.65

7.1

4.3

32.8

35.0

g/l

101.14

4256

23371

(3036481) Cortisol [Moles/volume] in Serum or Plasma

2777

4152

10.17

307.65

2.3

2.2

413.7

373.9

nmol/l

12.34

2541

3758

(3023183) Ammonium ion [Moles/volume] in Plasma

716

957

8.16

307.65

3.3

2.4

33.7

34.6

umol/l

0.36

609

800

(3002032) Base excess in Venous blood by calculation

1675

5094

3.96

307.65

5.9

3.2

1.9

2.0

mmol/l

0.81

1373

4098

(3013826) Glucose [Moles/volume] in Serum or Plasma

5393

33686

3.31

307.65

9.9

4.1

7.0

6.7

mmol/l

15.19

5240

31393

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

4090

23006

2.77

307.65

6.3

3.5

61.4

72.6

ng/l

0.17

3453

16818

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2186

6754

4.18

307.65

7.4

4.6

1.0

mmol/l

0.77

2047

6155

(3003181) Sodium [Moles/volume] in Urine

2749

653

66.87

307.65

1.6

1.2

56.8

63.8

mmol/l

4.00

2160

498

(3027945) Reticulocytes/100 erythrocytes in Blood

1759

6700

3.13

307.65

2.6

2.3

2.0

1.8

12.90

1525

5837

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1678

5123

3.94

307.65

5.9

3.2

5.7

5.8

kpa

5.36

1605

4964

(3016502) Oxygen saturation in Arterial blood

1668

5778

3.44

307.65

10.7

6.4

95.4

95.5

0.41

1614

5543

(3003396) Base excess in Arterial blood by calculation

1858

6478

3.50

307.65

10.2

6.1

1.2

mmol/l

0.08

1491

5008

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

4789

27088

3.23

307.65

11.7

5.0

1.2

mmol/l

111.65

4452

24084

(3008295) Osmolality of Serum or Plasma

1145

416

32.38

307.65

1.4

1.3

263.5

282.6

mosm/kgh2o

46.16

905

304

(3026782) Osmolality of Urine

3669

11306

5.51

307.65

3.5

2.7

401.9

549.9

mosm/kgh2o

308.26

3199

9481

(3000991) Gas panel - Venous blood

1456

4465

3.81

307.65

11.3

6.7

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1946

7378

3.22

307.65

3.3

2.2

20.5

21.9

3.48

1633

6155

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1842

6524

3.43

307.65

10.3

6.1

4.9

5.1

kpa

10.97

1763

6181

(3023368) Bacteria identified in Blood by Culture

3717

16221

3.63

307.65

5.7

4.0

—

(3016038) Potassium [Moles/volume] in Urine

1015

230

50.96

307.65

1.3

1.1

31.3

35.7

mmol/l

2.19

869

183

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2725

8724

4.38

307.65

4.6

2.9

0.8

mmol/l

65.94

2552

8027

(3032080) INR in Blood by Coagulation assay

4206

24237

2.73

307.65

11.7

9.3

1.2

1.3

inr

5.80

1445

6613

(3026008) Bacteria identified in Urine by Culture

3660

19514

2.75

307.65

4.9

3.3

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1611

4760

4.05

307.65

9.3

5.7

1.4

mmol/l

0.24

1523

4584

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

5130

29962

3.40

307.65

12.1

5.6

1.2

mmol/l

89.86

4225

24906

(3020779) Urea [Moles/volume] in Serum or Plasma

1502

4577

3.86

307.65

9.1

5.6

9.9

10.2

mmol/l

0.50

1428

4325

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1321

4180

3.63

307.65

2.0

1.6

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3601

17879

3.00

307.65

4.0

2.4

57.3

59.3

u/l

0.52

3359

16341

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2403

9593

3.24

307.65

2.2

1.8

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2052

7884

3.22

307.65

3.2

2.2

2.3

g/l

8.85

1876

7186

(3022948) Iron [Moles/volume] in Serum or Plasma

2181

8602

3.18

307.65

3.2

2.2

11.1

12.5

umol/l

13.75

1985

7826

(3014576) Chloride [Moles/volume] in Serum or Plasma

1842

7093

3.13

307.65

11.1

6.0

97.9

104.4

mmol/l

198.34

1789

6968

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3267

14737

3.20

307.65

2.8

2.2

3.1

mg/l

0.42

2804

12431

(3027801) Oxygen [Partial pressure] in Arterial blood

1842

6522

3.43

307.65

10.3

6.0

11.5

12.2

kpa

6.41

1758

6173

(3012544) pH of Venous blood

1695

5269

3.88

307.65

5.7

3.2

7.4

0.10

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

3558

17234

3.07

307.65

3.1

2.0

322.7

222.8

u/l

3.23

3374

15939

(3024354) Oxygen [Partial pressure] in Venous blood

1385

4309

3.72

307.65

5.3

2.8

4.5

4.4

kpa

0.82

1324

4160

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1668

6504

3.02

305.67

3.6

4.2

246.1

u/l

0.00

1551

6100

(3035637) Corticotropin [Mass/volume] in Plasma

421

545

8.11

305.13

1.6

1.4

—

(3019309) Folate [Moles/volume] in Red Blood Cells

2551

12504

2.59

299.36

2.1

1.7

1358.4

1182.3

nmol/l

13.41

1942

9189

(3006315) Basophils [#/volume] in Blood

4335

27224

2.45

293.44

7.5

5.5

0.0

e9/l

0.81

3848

23190

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3328

18584

2.45

293.23

4.0

2.9

2269.2

1505.7

ng/l

13.30

2902

15911

(3001604) Monocytes [#/volume] in Blood

4308

27052

2.44

290.54

7.5

5.5

0.7

0.6

e9/l

14.91

3827

23034

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1640

6511

2.95

289.36

2.1

1.7

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1073

3314

3.61

287.55

1.8

1.4

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1102

3465

3.56

287.34

5.6

3.4

5.1

5.2

kpa

1.91

1035

3175

(3013115) Eosinophils [#/volume] in Blood

4412

28087

2.44

287.19

7.9

5.7

0.2

e9/l

6.01

3944

24303

(3009343) pH of Capillary blood

1091

3412

3.57

286.81

5.6

3.4

7.4

0.03

196

438

(3019198) Lymphocytes [#/volume] in Blood

4374

27812

2.42

284.34

7.6

5.5

1.7

1.9

e9/l

10.43

3909

24149

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1631

6536

2.92

282.20

2.1

1.7

—

(3023520) Reticulocytes [#/volume] in Blood

1381

5044

3.13

281.81

2.6

2.5

72.7

68.1

e9/l

3.85

1085

3846

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1061

3296

3.59

281.53

5.5

3.3

2.1

mmol/l

0.02

813

2469

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1898

8248

2.75

281.50

2.4

1.9

30.1

29.9

0.54

1835

7985

(3013650) Neutrophils [#/volume] in Blood by Automated count

4793

31982

2.45

275.71

12.7

8.6

4.7

4.2

e9/l

36.85

4297

27650

(3019060) Gas panel - Arterial blood

1166

3909

3.35

274.02

7.2

4.3

—

(42870588) Differential panel, method unspecified - Blood

3285

18686

2.37

271.93

6.9

5.7

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

869

2437

3.90

267.57

5.7

3.5

24.1

24.2

mmol/l

0.53

784

2151

(3006504) Eosinophils/100 leukocytes in Blood

4026

25273

2.32

260.92

7.8

5.8

2.5

2.9

17.88

3786

23192

(3019069) Monocytes/100 leukocytes in Blood

4042

25424

2.32

260.60

8.3

6.1

9.1

8.8

7.57

3816

23436

(3002582) Erythrocytes [#/volume] in Urine

3106

17541

2.34

257.81

5.2

3.1

64.1

100.3

e6/l

1.10

2655

13316

(3000850) Epithelial cells [#/volume] in Urine

2433

12405

2.44

254.56

3.9

2.5

5.8

5.6

e6/l

0.22

2235

10752

(3022096) Basophils/100 leukocytes in Blood

3922

24538

2.29

253.63

7.8

5.8

0.6

0.7

11.55

3692

22541

(3002030) Lymphocytes/100 leukocytes in Blood

4077

26000

2.28

250.66

8.1

5.9

23.1

27.1

90.08

3814

23797

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

731

1902

4.15

249.19

2.3

2.1

539.5

678.0

ug/l

0.38

689

1789

(3004119) Hemoglobin [Mass/volume] in Venous blood

1031

3404

3.35

246.92

5.2

2.9

122.2

127.9

g/l

13.13

1016

3326

(3021960) Folate [Moles/volume] in Serum or Plasma

2661

14344

2.34

242.99

1.8

1.5

20.3

20.8

nmol/l

0.71

2331

11975

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1260

4745

2.99

240.86

2.5

1.7

1.9

1.5

27.30

1039

4105

(3018010) Neutrophils/100 leukocytes in Blood

3998

25597

2.24

239.28

7.6

5.7

61.2

57.8

51.08

3756

23568

(3009466) Valproate [Moles/volume] in Serum or Plasma

398

642

6.48

235.51

5.5

4.4

386.6

351.7

umol/l

4.00

352

536

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

672

1729

4.17

232.12

1.5

1.2

—

(3018095) Leukocytes [#/volume] in Urine

3369

20346

2.21

230.46

6.0

3.5

121.5

125.0

e6/l

0.07

2778

14399

(3014007) Fractional oxyhemoglobin in Arterial blood

1033

3568

3.20

228.74

13.1

7.5

93.5

93.9

1.12

1024

3559

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1029

3559

3.19

227.25

13.0

7.4

0.7

0.00

1021

3538

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

5858

44560

2.60

226.24

12.5

7.1

87.8

80.0

u/l

17.24

5607

41445

(3010421) pH of Blood

606

1472

4.39

225.73

5.9

3.5

7.4

0.26

522

1215

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

801

2381

3.64

225.05

2.2

1.8

2.1

2.6

ug/l

0.54

702

2050

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

842

2587

3.54

224.96

1.6

1.5

g/l

0.72

738

2183

(1616796) Gas panel - Central venous blood

531

1165

4.82

224.64

4.7

3.4

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1027

3574

3.17

224.31

12.9

7.3

1.5

1.4

1.39

1018

3553

(3037467) Urinalysis macro (dipstick) panel - Urine

5395

39666

2.38

222.77

7.3

4.5

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

883

2826

3.41

221.16

5.8

2.9

24.9

25.4

mmol/l

3.12

857

2749

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1040

3675

3.12

221.13

11.4

6.3

24.5

24.8

mmol/l

1.35

991

3422

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2855

16394

2.21

218.54

4.4

3.1

41.4

34.5

u/l

2.94

2701

15346

(3030467) Casts [#/volume] in Urine by Automated count

2840

16316

2.21

216.68

4.9

3.0

0.5

e6/l

0.12

2409

12284

(3013290) Carbon dioxide [Partial pressure] in Blood

539

1245

4.58

213.84

5.6

3.7

5.0

kpa

0.00

523

1214

(3012501) Base excess in Blood by calculation

538

1244

4.58

213.15

5.6

3.6

3.2

2.6

mmol/l

2.84

394

844

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

834

2646

3.42

211.41

5.0

2.4

0.7

4.14

823

2518

(3027315) Oxygen [Partial pressure] in Blood

539

1257

4.54

211.22

5.6

3.7

8.4

kpa

0.23

523

1226

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3832

25056

2.11

205.61

2.5

2.0

93.2

94.8

pmol/l

1.12

2094

12529

(40767503) Oxygen content in Capillary blood by calculation

513

1193

4.54

201.58

3.4

2.3

15.3

16.1

3.78

255

604

(3020630) Protein [Mass/volume] in Serum or Plasma

1212

4907

2.75

199.73

2.9

2.4

64.7

66.4

g/l

8.53

1090

4331

(3042936) Bacteria identified in Isolate by Culture

1653

7796

2.44

198.42

2.6

1.9

—

(36304419) Bacteria [Presence] in Urine

2715

15807

2.14

195.48

4.9

3.0

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3611

23396

2.07

194.99

2.9

2.1

78.0

80.2

nmol/l

4.35

3209

20363

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

847

2848

3.22

194.71

12.5

7.8

24.3

24.4

mmol/l

0.45

798

2621

(3015377) Calcium [Moles/volume] in Serum or Plasma

3268

20482

2.07

192.44

3.9

3.2

2.3

2.4

mmol/l

34.65

2820

17441

(3028271) Lactate [Moles/volume] in Capillary blood

427

901

4.96

188.76

2.5

1.6

1.7

mmol/l

0.45

419

877

(3020191) Ethanol [Moles/volume] in Serum or Plasma

243

298

8.37

183.55

1.9

1.2

1.4

1.3

promille

0.16

184

227

(3015235) Bicarbonate [Moles/volume] in Capillary blood

530

1359

4.11

182.93

4.3

2.8

24.8

25.2

mmol/l

1.11

480

1176

(3044640) Blood type and Crossmatch panel - Blood

2923

17832

2.06

182.70

3.5

2.4

—

(3007853) Bacteria identified in Skin by Aerobe culture

1423

6565

2.44

177.25

2.2

1.7

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

4610

33355

2.03

175.20

5.6

2.9

84.3

50.9

u/l

31.77

4266

30286

(3028626) Oxygen [Partial pressure] in Capillary blood

488

1217

4.21

174.71

5.5

2.9

8.0

kpa

0.20

459

1120

(3020891) Body temperature

748

2487

3.23

174.46

10.1

4.1

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

778

2673

3.13

171.58

6.6

3.4

50.7

47.5

2.84

772

2638

(3018405) Lactate [Moles/volume] in Arterial blood

673

2135

3.36

169.33

7.2

3.6

1.3

1.4

mmol/l

0.09

661

2111

(3022806) Fractional oxyhemoglobin in Capillary blood

356

718

5.15

165.63

2.4

1.6

88.9

89.6

0.98

348

706

(3022217) INR in Platelet poor plasma by Coagulation assay

1655

8476

2.23

159.78

24.3

28.4

1.3

1.5

inr

1.78

236

1141

(3011985) Renin [Units/volume] in Plasma

297

533

5.75

157.11

2.2

1.3

95.9

48.1

mu/l

0.76

258

476

(3022313) Gas panel - Capillary blood

720

2486

3.09

156.94

6.1

3.5

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2080

11708

2.08

156.94

2.0

1.6

1.7

1.4

mg/l

2.12

1704

8926

(3004588) Protein electrophoresis panel - Serum or Plasma

991

4083

2.64

155.22

2.6

2.2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

887

3479

2.76

153.00

2.0

1.6

—

(3035350) Ketones [Presence] in Urine by Test strip

3947

27893

1.90

150.70

6.3

3.9

0.0

estimate

0.50

1004

5177

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3747

26049

1.90

150.44

5.8

3.9

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1279

6016

2.36

150.28

3.9

2.6

11.0

9.1

umol/l

1.52

1098

5206

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1309

6228

2.34

149.74

6.1

3.3

—

(3021901) Oxygen saturation in Capillary blood

405

998

4.22

146.95

3.4

2.6

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

991

4226

2.55

143.97

4.6

3.0

103.5

87.6

ng/l

3.92

828

3505

(3021601) Nitrite [Presence] in Urine by Test strip

3923

27973

1.86

142.40

8.1

5.2

0.0

estimate

0.80

1028

5165

(3009261) Glucose [Presence] in Urine by Test strip

3955

28333

1.86

140.81

6.5

4.0

0.0

estimate

1.60

1007

5101

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

764

2889

2.83

140.79

13.6

8.5

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1165

5446

2.35

137.89

3.2

2.3

5.8

6.8

ug/l

1.28

961

4618

(3005719) IgG [Mass/volume] in Serum or Plasma

887

3659

2.61

137.70

3.2

2.8

10.8

10.6

g/l

0.67

804

3323

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1949

11201

2.00

135.56

5.9

3.6

252.9

462.0

ng/l

1.15

1679

9235

(3043409) Potassium [Moles/volume] in Arterial blood

569

1869

3.21

134.39

8.0

3.8

3.9

mmol/l

0.37

527

1792

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2211

13320

1.94

133.75

1.9

1.7

13891005.7

30870863.0

pmol/l

1.11

1771

10719

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1100

5109

2.35

131.70

6.2

3.2

1.2

mmol/l

16.85

1000

4319

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2242

13667

1.92

130.23

3.4

2.3

—

(3033658) Prothrombin time (PT) actual/Normal

2267

13874

1.91

130.09

6.7

3.7

85.4

87.3

2.89

2205

13538

(3017181) Myelocytes/100 leukocytes in Blood

1037

4737

2.38

128.77

4.6

3.9

1.0

0.9

0.35

415

1363

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

237

425

5.71

125.32

1.5

1.4

—

(3024928) Oxygen saturation in Venous blood

384

1022

3.90

125.15

2.9

2.8

—

(3029937) Albumin [Presence] in Urine by Test strip

2476

15766

1.86

124.37

7.0

4.3

0.0

estimate

1.71

965

5013

(40760892) CBC W Ordered Manual Differential panel - Blood

1922

11301

1.95

123.23

6.5

4.4

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

5261

42176

1.88

120.79

5.2

3.9

15.7

15.0

pmol/l

46.40

4808

37425

(3028026) IgM [Mass/volume] in Serum or Plasma

708

2811

2.67

117.93

1.9

1.8

1.2

1.5

g/l

3.27

639

2520

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

432

1309

3.43

115.95

1.6

—

(40758558) Short blood count panel - Blood

2231

14070

1.84

113.38

9.5

6.5

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

530

1842

3.01

113.17

3.1

3.0

69.0

54.6

mg/l

0.58

404

1488

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

519

1783

3.05

113.10

3.1

2.9

5.7

2.2

ratio

0.49

128

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

415

1247

3.46

112.81

5.1

3.3

1.8

1.6

mg/l

7.52

377

1131

(3021440) Promyelocytes/100 leukocytes in Blood

962

4494

2.31

112.48

4.6

3.9

0.1

0.16

377

1258

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

590

2184

2.84

112.33

6.8

3.6

24.8

25.0

mmol/l

1.08

548

1993

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

528

1840

3.01

112.19

3.2

3.0

39.3

54.2

mg/l

1.36

400

1493

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

439

1388

3.29

109.99

1.5

1.6

—

(3002179) Metamyelocytes/100 leukocytes in Blood

931

4329

2.31

109.90

4.4

3.8

0.7

0.6

0.39

299

981

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

414

1270

3.39

108.88

1.7

1.6

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1565

8973

1.94

105.87

4.4

2.8

2.7

2.8

e6/l

0.06

972

4853

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3085

21700

1.72

105.79

6.9

4.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

470

1598

3.07

104.12

2.1

1.6

—

(3013707) Erythrocyte sedimentation rate by Westergren method

5173

42044

1.78

103.84

5.6

4.1

18.7

13.4

mm/h

70.33

4783

38288

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1011

4974

2.19

103.71

3.9

2.4

33.4

50.1

u/l

1.04

851

4262

(40760888) Immunoglobulin light chains.free panel - Serum

423

1375

3.19

101.12

3.2

3.1

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

920

4413

2.23

100.28

1.8

1.5

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1559

9072

1.91

100.17

1.7

1.4

3.1

2.5

g/l

7.83

965

5126

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

137

176

7.89

99.40

2.6

2.3

60.3

56.6

umol/l

0.45

111

139

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

328

930

3.63

97.27

7.0

4.7

651.7

2423.3

iu/ml

0.51

129

(3000570) Elastase.pancreatic [Mass/mass] in Stool

464

1629

2.96

97.02

1.5

1.4

247.4

272.9

ug/g

1.72

275

977

(3047181) Lactate [Moles/volume] in Blood

469

1661

2.94

96.53

8.1

5.5

1.3

mmol/l

0.47

418

1456

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1658

9946

1.86

96.41

4.1

2.7

1.4

1.5

e6/l

0.07

1058

5765

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

232

515

4.61

95.96

1.3

505.4

262.0

pmol/l

0.93

174

400

(3021589) Normoblasts [#/volume] in Blood

3338

24418

1.67

95.70

18.4

9.4

0.0

e9/l

0.57

2870

19981

(3025159) Blasts/100 leukocytes in Blood

877

4214

2.22

94.90

4.8

3.9

0.2

0.3

0.21

312

1058

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

127

164

7.84

91.73

2.0

2.2

83.9

146.8

umol/l

1.29

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

335

1002

3.45

91.51

1.3

4.0

3.8

mmol/l

2.93

311

942

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1870

11794

1.78

91.43

3.5

3.1

2.5

mmol/l

0.18

1622

10268

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

364

1152

3.26

90.83

1.4

640.7

543.7

mg/l

0.59

342

1095

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

125

161

7.86

90.49

2.9

28.8

umol/l

0.01

128

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

6367

56056

2.06

89.50

35.7

14.3

26.0

25.5

mg/l

0.76

5972

44615

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

518

2016

2.68

89.05

2.7

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

607

2554

2.49

88.86

2.4

1.9

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

571

2336

2.56

88.69

2.2

1.7

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

324

970

3.44

88.35

1.6

1.7

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

505

1952

2.70

87.97

3.3

2.7

0.3

0.4

u/ml

2.45

303

1096

(46235355) HIV 1 and 2 tests - Meaningful Use set

1066

5697

2.01

86.71

1.9

1.6

—

(3044290) Cell count panel - Cerebral spinal fluid

304

887

3.52

86.25

1.5

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

562

2321

2.53

85.50

7.5

4.6

1.7

1.6

0.70

530

2165

(3026250) Tacrolimus [Mass/volume] in Blood

110

133

8.36

83.91

40.7

32.3

7.1

7.3

ug/l

0.30

115

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

129

189

6.91

83.31

16.6

17.8

1484.1

1402.5

nmol/l

0.45

123

181

(3030313) Adrenal Ab [Titer] in Serum

31.89

83.08

1.1

1.0

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

958

4998

2.05

83.07

1.8

1.5

—

(40768797) Stomach Pathology biopsy report

1309

7616

1.87

82.32

1.4

1.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

379

1304

3.00

81.95

2.9

2.1

123.9

128.4

g/l

2.84

312

914

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

316

978

3.32

81.70

1.4

1.5

25.5

16.5

e6/l

0.38

258

787

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

316

980

3.31

81.42

1.4

1.5

695.2

1405.6

e6/l

1.06

276

819

(3013512) EKG study

2557

18030

1.64

80.60

5.8

3.9

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

152

272

5.67

80.50

2.4

2.2

16.0

17.3

nmol/l

0.78

137

255

(3028707) Methadone [Presence] in Urine by Screen method

172

347

5.04

79.75

4.1

2.9

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

168

334

5.11

79.22

1.5

1.3

2.5

2.1

mmol/l

0.97

157

312

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

123

183

6.80

78.31

11.6

13.2

762.3

805.2

nmol/l

0.37

117

171

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

995

5372

1.98

78.03

3.9

2.8

264.6

222.2

ng/l

1.87

918

4885

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1669

10591

1.74

77.97

1.3

1.2

2.1

1.8

u/ml

0.22

430

2684

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

267

765

3.57

77.84

1.6

1.5

—

(3037522) Nuclear Ab [Titer] in Serum

1138

6453

1.90

77.06

1.4

1.3

589.5

532.8

titre

0.43

275

1421

(3007566) Smooth muscle Ab [Titer] in Serum

358

1241

2.97

76.33

1.3

1.2

161.3

117.7

titre

0.44

(3019230) Fractional oxyhemoglobin in Venous blood

283

857

3.38

75.72

3.0

2.5

61.7

63.0

0.38

278

852

(3025941) Bacteria identified in Stool by Culture

608

2764

2.30

74.42

1.5

1.2

—

(3034770) Mitochondria Ab [Titer] in Serum

351

1242

2.91

72.08

1.2

837.0

953.0

titre

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

614

2849

2.25

71.49

4.1

2.5

0.3

e6/l

0.11

592

2783

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1141

6629

1.85

71.11

3.4

4.0

14.0

23.3

ug/l

1.69

967

5456

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

524

2278

2.39

70.99

2.8

2.0

7.5

g/l

0.11

383

1642

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

346

1225

2.91

70.97

1.5

—

(40761536) Microorganisms panel - Urine sediment

911

4921

1.97

70.90

7.1

4.0

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

528

2305

2.38

70.86

7.6

4.6

0.9

0.24

498

2150

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

523

2274

2.39

70.82

2.7

2.0

3.7

3.8

g/l

0.17

372

1569

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

523

2275

2.39

70.75

2.8

2.0

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

5853

51146

1.72

70.64

6.4

4.6

2.0

2.1

mu/l

1.58

5406

45625

(3009508) Creatinine [Moles/volume] in Urine

2453

17558

1.59

70.30

3.8

3.0

5.3

7.2

mmol/l

114.11

2022

14373

(3041096) Erythrocytes [Presence] in Urine by Automated

2089

14423

1.62

69.38

6.1

3.6

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

602

2806

2.24

69.26

3.0

4.0

4.4

pmol/l

14.55

514

2431

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

296

978

3.10

68.58

1.6

1.4

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

515

2271

2.36

67.47

1.3

1.6

6.4

19.7

u/ml

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

240

708

3.46

66.88

4.3

2.6

37133.5

1348.9

u/ml

0.58

(3037756) Immunofixation for Serum or Plasma

336

1226

2.82

65.13

1.6

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

485

2122

2.37

64.63

2.8

2.1

3.2

3.1

g/l

0.38

373

1604

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

219

623

3.58

64.52

1.7

1.5

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1974

13638

1.61

64.48

6.0

3.9

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

112

185

6.11

64.45

2.6

1.9

1419.4

3150.6

e6/l

0.29

135

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

330

1205

2.81

63.87

1.5

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

267

868

3.14

63.57

1.6

1.4

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

240

732

3.35

63.46

1.8

2.2

32.8

32.5

0.30

235

726

(44816559) Phosphatidylethanol [Mass/volume] in Blood

233

701

3.39

62.96

1.9

1.3

—

(3020682) Albumin/Creatinine [Ratio] in Urine

2459

17995

1.55

62.04

4.6

3.7

21.4

6.9

mg/mmol

16.02

1587

10809

(3000494) Fungus identified in Specimen by Culture

1058

6247

1.81

61.84

1.6

1.4

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

481

2142

2.33

61.49

2.7

2.1

10.2

10.5

g/l

0.47

408

1733

(3037121) Protein [Mass/volume] in Urine

448

1941

2.39

60.97

3.9

2.9

0.3

g/l

0.11

224

710

(3026493) Urate [Moles/volume] in Serum or Plasma

2050

14469

1.57

60.39

3.3

2.5

3025.0

6050.8

umol/l

3.42

1704

12194

(3003434) Protein [Mass/volume] in Pleural fluid

256

837

3.12

60.36

1.6

1.4

31.0

32.0

g/l

0.51

230

750

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

121

233

5.25

59.19

1.2

1.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

159

6.28

58.59

2.5

1.7

9148.8

20360.5

e6/l

0.46

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

119

228

5.27

58.54

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

178

474

3.81

57.78

1.6

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

244

797

3.12

57.62

1.5

1.4

—

(40761535) Cells panel - Urine sediment

925

5350

1.83

57.59

5.6

3.5

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

435

1917

2.34

56.90

2.7

2.1

0.8

1.1

g/l

0.74

366

1596

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3557

28502

1.48

56.16

2.9

2.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

237

773

3.13

56.11

1.6

1.4

—

(3012516) Albumin [Mass/volume] in Urine

2320

17069

1.52

55.65

3.8

3.0

673.0

372.3

mg/l

1.71

1530

10369

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

227

727

3.18

55.42

6.0

6.2

12.6

11.9

mg/l

1.03

211

658

(3019977) pH of Arterial blood

131

291

4.55

54.16

3.3

2.4

7.4

0.03

127

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

10.58

53.90

4.3

4.6

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

136

314

4.38

53.56

2.3

1.9

—

(3004809) Band form neutrophils/100 leukocytes in Blood

269

975

2.82

52.75

3.5

3.6

1.4

0.11

202

751

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

254

900

2.88

51.95

4.4

2.5

—

(4198724)

102

7.40

51.82

3.3

3.7

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

327

1320

2.54

51.80

1.5

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

327

1320

2.54

51.80

1.5

1.3

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

396

1745

2.33

51.74

1.7

1.6

125.7

280.0

titre

1.46

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

337

1381

2.50

51.71

2.7

2.4

3.6

g/l

0.27

318

1307

(3026692) Albumin [Mass/volume] in Peritoneal fluid

134

6.39

51.25

1.8

1.5

11.4

14.6

g/l

1.94

(3033799) Differential panel - Peritoneal fluid

155

5.91

50.79

2.2

1.7

—

(3036782) Glucose [Moles/volume] in Pleural fluid

180

531

3.44

50.18

1.4

1.3

6.8

6.3

mmol/l

1.20

167

485

(1001926) Buprenorphine [Presence] in Urine by Screen method

196

611

3.26

50.04

3.7

2.3

—

(3036489) Thrombin time

396

1774

2.30

49.77

2.2

2.0

21.4

21.6

0.28

365

1556

(3019150) Specific gravity of Urine by Refractometry

1782

12640

1.54

49.56

6.9

4.5

1.0

kg/l

12.68

251

1915

(3042631) Mycobacterium sp identified in Specimen

239

843

2.89

49.29

2.6

2.8

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

102

201

5.12

48.65

1.2

50.2

65.9

0.68

(3019550) Sodium [Moles/volume] in Serum or Plasma

6435

59118

1.74

48.34

47.4

16.5

134.7

139.7

mmol/l

307.65

6315

57385

(3040151) Glucose [Moles/volume] in Capillary blood

200

645

3.15

48.27

6.8

15.3

7.6

7.1

mmol/l

0.97

169

523

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

220

750

2.98

48.24

2.0

1.8

27.7

23.5

ug/l

0.36

211

732

(3010375) cycloSPORINE [Mass/volume] in Blood

185

5.28

48.00

32.3

25.6

106.1

113.0

ug/l

0.51

156

(3011288) Drugs identified in Urine by Screen method

173

514

3.41

47.71

4.9

3.1

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

201

655

3.12

47.67

1.2

1.3

0.6

0.7

nmol/l

0.10

188

628

(3019225) pH of Specimen

1023

6423

1.68

47.09

7.2

3.8

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

200

661

3.07

46.30

1.2

1.3

0.2

0.3

nmol/l

0.55

(3023103) Potassium [Moles/volume] in Serum or Plasma

6436

59257

1.72

46.29

46.1

16.6

4.0

mmol/l

36.49

6310

57409

(3023199) Leukocytes [#/volume] in Pleural fluid

216

746

2.94

46.29

1.7

1.5

3204.0

2455.5

e6/l

0.30

181

551

(3021387) Prolactin [Units/volume] in Serum or Plasma

244

903

2.75

45.99

2.3

1.7

390.0

300.9

mu/l

2.20

225

827

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

178

552

3.27

45.85

1.5

1.7

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

184

583

3.20

45.75

1.3

—

nmol/l

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

279

1110

2.57

45.53

4.4

3.5

60.4

57.9

2.00

279

1110

(3042733) HLA Ab [Presence] in Serum

7.00

45.47

4.8

4.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

186

596

3.17

45.39

1.2

1.3

—

(3039000) Anion gap in Blood

295

1208

2.49

45.31

10.2

6.2

11.9

11.1

mmol/l

2.53

271

1068

(3018572) Chloride [Moles/volume] in Blood

295

1209

2.49

45.23

10.2

6.2

98.3

105.1

mmol/l

34.98

271

1069

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

133

343

3.92

45.22

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

386

1783

2.22

45.03

2.5

1.9

35.8

37.3

g/l

4.41

333

1463

(3016018) Differential panel - Cerebral spinal fluid

157

455

3.49

45.01

1.6

—

(40768446) Kidney Pathology biopsy report

136

5.92

44.76

2.0

1.5

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

201

682

2.99

44.46

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

134

353

3.84

44.23

2.3

2.4

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

319

1378

2.37

43.57

1.8

1.5

0.2

g/l

2.23

299

1296

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

326

1422

2.35

43.55

1.9

1.5

1.1

1.2

g/l

3.83

308

1339

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

224

817

2.79

43.42

2.0

1.3

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

176

564

3.16

42.96

1.3

536.8

322.6

u/l

0.79

167

532

(3021879) Hepatitis B virus core Ab [Presence] in Serum

535

2842

1.95

42.85

1.4

1.3

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

360

1650

2.24

42.78

2.6

2.0

0.0

g/l

0.28

334

1480

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

142

399

3.60

42.68

1.3

1.4

—

(3016879) Cocaine [Presence] in Urine

207

731

2.88

42.62

3.7

2.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

110

6.40

42.36

1.2

1.1

—

(3023419) Bacteria identified in Sputum by Culture

202

707

2.90

42.27

2.1

2.5

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

271

1106

2.50

41.92

1.5

1.6

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

145

5.55

41.87

1.3

1.4

16.5

15.9

pmol/l

0.46

115

(44806118)

175

569

3.12

41.69

1.6

1.4

—

(44790047)

175

569

3.12

41.69

1.6

1.4

—

(44790048)

175

569

3.12

41.69

1.6

1.4

—

(44790049)

175

569

3.12

41.69

1.6

1.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

102

229

4.49

41.67

1.8

1.5

—

(3052851) Hemolysis interference index of Serum or Plasma

367

1714

2.19

41.64

4.4

3.1

—

(3044007) Cell count panel - Peritoneal fluid

150

5.43

41.43

2.7

1.7

—

(40768806) Pleura Pathology biopsy report

190

654

2.95

40.98

1.6

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

221

827

2.72

40.79

1.9

1.3

19.3

17.6

u/ml

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

137

389

3.56

40.55

1.4

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

195

685

2.89

40.54

1.6

1.5

46830.0

59489.5

e6/l

0.30

137

412

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

163

517

3.19

40.49

2.8

2.7

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

136

5.62

40.33

4.3

2.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

136

5.62

40.33

4.3

2.1

—

(3000764) Benzodiazepines [Presence] in Urine

213

787

2.75

40.29

3.8

2.2

—

(3020876) Protein [Mass/time] in 24 hour Urine

140

408

3.47

39.83

1.8

0.5

1.1

g/24h

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

153

473

3.27

39.64

1.5

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

153

473

3.27

39.64

1.5

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

153

473

3.27

39.64

1.5

1.7

—

(3028300) Cannabinoids [Presence] in Urine

211

796

2.69

38.34

4.1

2.1

—

(3011648) Oxygen content in Venous blood

128

362

3.57

38.13

2.7

10.6

10.8

0.21

128

362

(3027008) Opiates [Presence] in Urine

210

793

2.69

38.09

3.9

1.9

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

205

766

2.72

37.96

1.6

1.2

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

113

5.96

37.82

1.4

1.3

22.0

27.2

g/l

1.35

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

332

1552

2.19

37.56

2.7

2.0

0.0

g/l

0.38

307

1387

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

327

1524

2.19

37.27

2.7

2.0

0.0

g/l

0.00

305

1383

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

222

873

2.58

37.13

1.2

1.3

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

144

5.24

36.89

3.3

2.2

128.8

142.9

nmol/l

0.62

127

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

192

704

2.77

36.87

1.6

1.2

279.1

288.7

u/ml

0.17

134

410

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

196

727

2.73

36.82

2.0

1.3

114.4

121.5

u/ml

0.35

166

(3012441) Differential panel - Pleural fluid

181

644

2.85

36.78

1.6

1.5

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

748

4599

1.69

36.71

4.2

2.5

55.9

62.8

ml/min/173m2

4.03

345

1828

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

157

519

3.06

36.39

1.6

1.7

—

(4035726)

821

5193

1.65

36.11

1.5

1.4

—

(3035880) pH of Pleural fluid

115

315

3.68

35.94

1.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

101

253

4.02

35.81

2.0

2.1

—

(3027944) Amphetamines [Presence] in Urine

203

778

2.65

35.77

3.7

2.2

—

(21494890) Protein electrophoresis panel - 24 hour Urine

162

551

2.97

35.73

2.1

1.8

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

301

1387

2.21

35.28

2.4

2.2

87.1

90.1

1.12

286

1307

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

121

348

3.51

35.16

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

188

711

2.68

34.03

1.5

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

189

725

2.64

33.26

1.5

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

187

715

2.65

33.13

1.5

1.4

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

136

437

3.14

33.12

1.2

1.3

10.8

12.2

u/l

0.54

121

400

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

188

722

2.64

33.01

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

187

717

2.64

32.94

1.5

1.4

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

185

706

2.65

32.90

2.4

2.5

81.1

736.5

u/ml

0.94

177

695

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

190

738

2.61

32.61

1.5

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

186

716

2.63

32.51

1.5

1.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

243

1060

2.33

32.46

1.6

1.2

—

(3048689) Calprotectin [Mass/mass] in Stool

867

5715

1.58

31.97

2.3

2.1

229.1

147.1

ug/g

3.88

660

4399

(3009214) Lutropin [Units/volume] in Serum or Plasma

212

879

2.45

31.74

1.6

1.4

12.6

11.0

u/l

0.63

168

710

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

161

583

2.79

31.71

1.2

52.1

59.1

u/l

1.07

114

372

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

206

844

2.47

31.65

1.5

1.4

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

102

283

3.63

31.33

2.4

2.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

124

3394

0.35

31.19

1.6

1.8

—

(3045788) Cell count panel - Pleural fluid

157

566

2.80

31.18

1.7

1.5

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

274

1278

2.18

31.17

2.6

2.4

220.9

197.8

2.75

259

1211

(3017569) Oxygen content in Arterial blood

101

281

3.62

30.90

1.9

2.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

316

1563

2.06

30.86

3.7

3.2

0.8

nmol/l

0.42

238

1216

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

186

737

2.56

30.67

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

189

757

2.53

30.47

1.4

1.6

0.6

0.8

g/l

1.68

133

570

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

5.73

30.47

1.0

1.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

165

621

2.69

30.18

3.4

3.8

61.6

57.7

1.10

400

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

144

505

2.88

30.11

1.5

1.7

29.0

26.5

u/ml

0.18

114

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

113

344

3.31

30.10

1.7

1.5

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

188

4.22

30.05

3.1

2.6

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

113

345

3.30

29.96

1.7

1.5

—

(21494755) Public health laboratory ask at order entry panel

103

3024

0.33

29.93

1.3

1.4

—

(3012565) Volume of 24 hour Urine

210

4.02

29.92

1.9

2.4

2123.5

1871.6

0.98

176

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

282

1353

2.12

29.86

2.6

3.2

868.6

607.0

u/ml

0.20

254

1231

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

121

386

3.16

29.86

1.7

1.5

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

203

4.06

29.60

4.0

3.5

74.0

68.7

mg/l

0.22

133

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

6.78

29.53

1.8

3.5

38.3

41.2

umol/l

0.34

(3004451) EKG impression Narrative

257

3.68

29.52

1.4

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

550

3298

1.72

29.40

2.7

2.4

—

(3024471) HLA-A [Type]

120

5.10

29.25

1.0

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

167

644

2.62

29.12

3.7

4.3

—

(42529406) Shigella sp [Presence] in Stool by Culture

308

1543

2.03

29.05

1.4

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

307

1537

2.03

29.01

1.4

1.2

—

(3024932) HLA-DR beta [Type]

118

5.10

28.78

1.0

1.2

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

281

3.51

28.68

1.3

1.2

205.0

323.7

u/l

1.13

266

(3044927) Protein electrophoresis panel - Urine

158

598

2.67

28.61

1.3

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

108

5.29

28.50

1.0

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

5.47

27.99

1.5

1.3

228.9

59.5

mu/l

0.62

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

303

1531

2.02

27.91

1.4

1.2

—

(3023410) Appearance of Cerebral spinal fluid

122

413

2.98

27.22

1.6

1.7

—

(3014271) Vancomycin [Susceptibility]

112

361

3.13

27.20

3.8

3.0

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

116

382

3.06

27.16

1.1

—

(3042517) Benzodiazepines panel - Urine

15.00

26.97

2.5

1.8

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

104

323

3.24

26.86

2.6

1.6

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

281

3.40

26.53

1.4

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

281

3.40

26.53

1.4

1.5

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

122

422

2.91

26.21

1.4

13.1

12.7

u/l

0.24

116

399

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

130

4.63

25.72

1.1

—

(40761511) CBC panel - Blood by Automated count

6182

57850

1.44

25.62

33.5

13.8

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

235

3.59

25.55

1.4

61.3

66.8

0.73

188

(3013005) Retinol [Moles/volume] in Serum or Plasma

168

4.12

25.51

3.0

1.5

2.0

umol/l

0.21

159

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

114

388

2.96

25.22

1.2

1.1

—

u/ml

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

104

336

3.12

25.18

1.2

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

230

1094

2.13

24.94

1.7

1.6

3.7

4.3

iu/l

0.49

338

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

132

4.48

24.33

1.2

1.1

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

193

3.80

24.12

1.3

1.4

4.3

2.7

0.74

154

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

117

4.71

24.12

1.6

1.2

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6328

59613

1.45

23.94

18.1

10.2

25.1

25.2

u/l

0.05

6162

56828

(4062490)

128

480

2.69

23.67

1.5

1.3

—

(3045716) Anion gap in Serum or Plasma

263

3.33

23.52

2.7

2.2

8.4

9.2

mmol/l

0.73

205

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

140

4.30

23.48

1.3

38.4

24.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

304

3.14

23.41

3.8

4.0

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

2208

0.31

23.40

1.4

1.5

—

(3005322) IgE [Units/volume] in Serum or Plasma

457

2779

1.68

23.11

1.3

491.2

236.0

u/ml

1.50

413

2543

(3042111) Morphology [Interpretation] in Bone marrow Narrative

205

961

2.16

23.09

1.5

1.6

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

148

605

2.47

22.94

1.1

1.6

1.5

g/l

1.82

127

534

(3000093) Morphology [Interpretation] in Blood Narrative

137

540

2.56

22.93

1.1

—

(3051651) Icteric interference index of Serum or Plasma

300

3.12

22.62

3.8

2.6

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

184

3.76

22.55

1.9

1.6

6.5

6.1

nmol/l

0.05

151

(3044889) 12 lead EKG panel

4502

40496

1.28

22.35

5.4

3.9

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

225

1109

2.05

22.24

1.4

1.3

—

(3000012) Reticulocyte production index

100

341

2.95

22.10

1.4

1.5

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

7.03

21.93

2.0

2.3

17.3

17.8

umol/l

0.08

(3024891) Influenza virus A+B Ag [Presence] in Specimen

254

1314

1.96

21.92

1.3

1.2

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

104

365

2.87

21.83

1.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

355

2045

1.77

21.82

1.5

1.8

39.0

39.6

u/l

0.19

299

1770

(3027135) IgG subclass 1 [Mass/volume] in Serum

125

486

2.59

21.54

1.4

1.3

6.9

6.8

g/l

0.06

338

(3028192) IgG subclass 2 [Mass/volume] in Serum

125

486

2.59

21.54

1.4

1.3

2.7

2.9

g/l

0.81

337

(3024139) IgG subclass 3 [Mass/volume] in Serum

125

486

2.59

21.54

1.4

1.3

0.4

g/l

0.37

338

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

119

452

2.65

21.49

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

100

347

2.90

21.43

3.8

2.2

24.1

30.6

umol/l

0.31

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

5680

52800

1.33

21.39

33.1

13.5

76.1

75.7

ml/min/173m2

0.58

5035

43393

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

105

4.68

21.33

1.2

294.0

296.5

pmol/l

0.02

(3051611) Lipemic interference index of Serum or Plasma

141

586

2.43

21.12

3.7

2.7

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

193

3.59

21.06

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

5629

52300

1.32

20.97

7.6

5.8

41.8

39.9

mmol/mol

28.96

5140

47225

(3003694) ABO and Rh group [Type] in Blood

1746

14008

1.32

20.89

1.4

1.3

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

189

895

2.13

20.79

3.8

1.7

0.9

0.8

nmol/l

1.10

157

745

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

368

2175

1.72

20.66

2.8

3.4

1109.4

1586.6

u/ml

0.26

317

1851

(3011412) CD3 cells [#/volume] in Blood

120

468

2.58

20.57

2.4

1.0

1.1

e9/l

0.30

292

(3008116) Ketones [Moles/volume] in Urine by Test strip

5.07

20.57

1.8

1.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

102

367

2.80

20.47

1.1

1.2

120.0

141.2

titre

0.24

(3029634) Reagin Ab [Titer] in Serum by VDRL

129

523

2.48

20.40

1.9

1.8

—

2.6

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

244

3.21

20.01

1.4

1.2

—

(3002385) Erythrocyte distribution width [Ratio]

4897

44772

1.28

20.01

39.9

17.4

14.2

13.8

65.30

4820

43577

(3015171) Extractable nuclear Ab [Units/volume] in Serum

326

1883

1.76

19.86

1.2

1.5

1.3

u/ml

0.11

170

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

6.60

19.46

1.2

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

244

1302

1.90

19.24

2.5

2.2

197.6

80.2

ug/min

1.94

139

732

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

136

3.98

19.16

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

185

899

2.08

19.05

1.3

37.4

40.7

u/l

0.16

157

773

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

263

1460

1.83

18.32

1.7

1.6

0.2

7.3

iu/ml

1.00

332

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

4.50

18.31

1.0

1.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

274

2.97

18.23

1.6

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

274

2.97

18.23

1.6

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

274

2.97

18.23

1.6

1.9

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

5.93

18.13

1.8

1.6

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

103

4.38

18.11

3.9

2.7

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

314

2.82

17.99

1.1

307.0

288.1

mg/l

0.60

279

(3022145) Colonoscopy Study observation

835

6111

1.41

17.78

1.4

1.3

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

323

2.77

17.63

1.2

107.7

92.1

u/l

0.63

268

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

274

2.93

17.63

1.6

1.9

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

101

392

2.59

17.55

1.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

314

2.78

17.42

1.1

1.2

30.6

26.5

u/l

0.32

252

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

108

435

2.50

17.38

1.6

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

137

3.80

17.36

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

225

3.12

17.22

1.2

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

251

3.00

17.22

1.1

4.0

3.4

iu/ml

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

5.32

17.20

1.1

1.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

278

2.89

17.18

1.3

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

278

2.89

17.18

1.3

1.5

—

(3026389) Candida sp identified in Specimen by Organism specific culture

162

780

2.09

17.13

1.2

1.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

112

4.11

17.11

1.1

—

(21494815) CD4 cells/100 lymphocytes in Specimen

375

2.60

17.00

2.5

2.3

32.2

37.9

0.52

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

156

744

2.11

16.92

1.9

1.5

—

(3020961) Endomysium IgA Ab [Titer] in Serum

346

2136

1.65

16.51

1.1

535.0

194.3

titre

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

106

434

2.46

16.50

1.3

1.1

1.4

nmol/l

3.53

388

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

262

1503

1.77

16.39

2.1

1.7

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

5.54

16.39

7.3

9.7

5.8

mmol/l

0.01

(3004716) Salmonella sp identified in Stool by Organism specific culture

348

2161

1.64

16.23

1.4

1.3

—

(3017732) Neutrophils [#/volume] in Blood

549

3778

1.49

16.21

4.4

3.0

4.6

4.1

e9/l

2.45

370

2770

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

11.32

16.14

2.3

2.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

11.32

16.14

5.9

1.7

—

(3001186) Copper [Moles/volume] in Serum or Plasma

4.63

15.99

1.6

1.0

16.8

16.6

umol/l

0.04

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

127

3.79

15.96

1.1

—

(3045142) Bone marrow Pathology biopsy report

128

578

2.23

15.95

1.4

1.3

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

232

1296

1.81

15.88

1.5

1.8

10.8

11.4

mg/l

0.52

205

1187

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

138

3.63

15.65

1.8

1.4

3.1

3.3

umol/l

0.12

126

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

405

2.46

15.46

1.6

1.4

39.7

32.7

u/l

0.90

333

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

5.58

15.45

1.3

1.8

—

(3049717) Cytology report of Urine Cyto stain

365

2329

1.59

15.24

2.4

2.8

—

(3045414) Leukocytes [Presence] in Urine

392

2545

1.57

15.19

2.7

1.9

—

(3007461) Platelets [#/volume] in Blood

6452

61778

1.36

15.16

50.2

21.3

263.9

246.2

e9/l

60.99

6315

59817

(3035941) MCH [Entitic mass]

6453

61795

1.36

15.10

49.9

21.2

30.5

30.4

8.99

6353

60579

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

102

428

2.40

15.09

1.3

30.0

73.1

titre

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

368

2.51

15.08

2.3

2.1

12.4

14.4

0.68

154

(3024731) MCV [Entitic volume]

6453

61797

1.36

15.08

50.0

21.2

91.3

91.4

1.19

6357

60581

(3026361) Erythrocytes [#/volume] in Blood

6453

61803

1.36

15.02

50.2

21.3

4.1

4.4

e12/l

307.65

6298

59615

(3010813) Leukocytes [#/volume] in Blood

6453

61812

1.36

14.93

50.3

21.3

7.4

6.8

e9/l

47.19

6294

59597

(3000963) Hemoglobin [Mass/volume] in Blood

6453

61813

1.36

14.92

50.8

21.4

123.4

133.9

g/l

307.65

6354

60613

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

273

2.76

14.84

3.5

2.9

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

135

645

2.11

14.63

1.1

86.6

92.2

iu/ml

0.03

147

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

103

441

2.35

14.58

1.3

270.0

604.9

titre

0.79

(3027923) C peptide [Moles/volume] in Serum or Plasma

254

2.80

14.52

1.3

1.2

nmol/l

0.10

197

(3018133) Calcium [Moles/volume] in Urine

5.38

14.39

1.6

1.5

2.4

2.5

mmol/l

0.14

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

313

2.60

14.28

2.0

2.7

952.2

535.1

e6/l

0.43

263

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

149

747

2.01

14.20

1.3

1.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

4.84

14.17

1.1

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

350

2.50

14.12

1.5

8.2

7.7

u/l

0.05

151

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

247

2.80

14.11

1.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

292

2.65

14.10

1.2

1.1

28.1

28.7

u/l

0.04

221

(3026726) Creatinine [Moles/volume] in Specimen

6.39

14.02

2.3

1.8

294.9

704.0

umol/l

0.36

(3034274) Bile acid [Moles/volume] in Serum --fasting

305

2.60

13.96

1.9

12.3

9.1

umol/l

0.55

220

(3023383) Lactate [Moles/volume] in Pleural fluid

180

3.12

13.85

1.2

1.3

3.8

3.2

mmol/l

0.36

165

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

186

3.07

13.75

2.3

1.8

250.0

16172.9

u/ml

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

343

2.49

13.72

2.5

2.1

—

(3009542) Hematocrit [Volume Fraction] of Blood

5242

49067

1.23

13.70

33.6

15.7

35.7

39.1

87.00

2880

31815

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

286

2.63

13.60

1.1

319.6

283.1

mg/l

0.62

247

(4027681)

214

2.90

13.57

1.4

1.2

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

4.22

13.52

1.4

1.1

2.7

2.2

mmol/l

0.11

(3006922) Hepatitis E virus Ab [Presence] in Serum

287

2.62

13.51

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

105

3.81

13.49

1.1

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

293

2.60

13.49

1.3

1.1

107.8

91.1

u/l

0.44

225

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

312

2.54

13.35

2.4

2.7

1965.1

613.1

e6/l

0.51

135

(3047189) Immunofixation for 24 hour Urine

238

2.78

13.34

1.7

1.6

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

154

3.25

13.28

1.1

1413.8

1558.9

miu/ml

0.37

154

(3046861) Legionella sp Ag [Presence] in Urine

6.56

13.12

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

192

2.97

13.04

3.3

2.2

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

4.75

12.98

1.4

1.3

78.3

72.3

0.47

(40768804) Tissue Pathology biopsy report

2610

22926

1.21

12.92

2.3

2.2

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

300

2.54

12.87

1.2

1.1

49.0

39.8

mg/l

0.89

245

(3016750) Collection duration of Urine

306

2.52

12.86

2.1

516.6

489.6

min

1.19

223

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

22.48

12.85

3.4

4.5

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

22.48

12.85

3.4

3.9

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

8.09

12.70

3.6

2.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

100

450

2.23

12.66

1.2

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

4.37

12.53

1.5

1.2

224.5

81.6

u/l

0.42

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

5.45

12.51

2.6

1.8

45.2

57.2

0.70

(3017704) Immunofixation for Urine

275

2.59

12.51

1.6

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

275

2.59

12.51

1.1

—

(36660697) Celiac disease serology panel - Serum

528

3799

1.42

12.29

1.2

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1032

8225

1.29

12.22

16.2

7.4

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

302

2.49

12.21

2.1

2.7

0.2

e9/l

0.79

261

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

3.74

12.17

1.4

7.7

10.8

0.46

(3020393) Adenovirus Ag [Presence] in Stool

4.74

12.05

1.7

1.4

—

(3051593) INR in Capillary blood by Coagulation assay

316

2.44

12.04

6.9

13.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

3.81

11.81

1.4

4.0

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

5.83

11.73

2.5

1.6

13.7

19.8

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

388

2.28

11.73

1.1

1.0

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

255

2.59

11.71

1.7

1.5

4.8

6.0

u/l

1.76

206

(3022621) pH of Urine by Test strip

534

3884

1.40

11.68

4.5

3.4

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

194

2.84

11.63

1.1

805.6

311.0

ng/l

0.70

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

298

1935

1.56

11.60

1.1

0.8

1.7

u/ml

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.57

11.57

1.1

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

18.87

11.55

1.1

1.0

—

mmol/l

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

153

832

1.85

11.54

3.0

2.1

31.6

25.3

mg/l

0.63

208

(3036603) Volume of Urine

294

2.46

11.41

1.5

1.7

1889.0

1881.6

0.01

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

115

571

2.02

11.35

1.5

23.1

31.4

1.97

355

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

109

532

2.06

11.27

1.2

1.3

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

119

3.36

11.27

1.4

1.2

1.5

1.8

mmol/l

0.67

(3032057) Clostridioides difficile [Presence] in Stool

129

3.26

11.25

1.9

1.7

—

(3028433) Virus identified in Specimen by Culture

193

2.80

11.16

1.2

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

116

585

1.99

10.98

3.7

—

(3013727) Leukocytes other/100 leukocytes in Blood

173

2.89

10.96

2.8

3.2

59.4

54.5

0.85

166

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

264

2.51

10.94

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

264

2.51

10.94

1.1

—

(44786800) Granulocytes/100 leukocytes in Body fluid

3.75

10.93

1.3

1.4

24.8

22.3

0.15

(3037692) Legionella sp identified in Specimen by Organism specific culture

196

2.76

10.85

1.2

1.3

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

4.54

10.64

1.3

1.5

—

(3041354) Potassium [Moles/volume] in Venous blood

148

819

1.82

10.59

3.6

2.2

4.1

mmol/l

1.06

148

813

(3035285) Chloride [Moles/volume] in Venous blood

148

819

1.82

10.59

3.6

2.2

99.5

105.6

mmol/l

17.86

148

813

(21494434) Karyotype in Bone marrow

101

492

2.06

10.53

1.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

126

3.18

10.32

1.9

1.7

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

147

3.00

10.28

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

142

3.03

10.25

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

208

1279

1.64

10.21

3.4

2.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

175

2.80

10.17

1.1

1.3

189.5

362.6

ug/l

0.30

105

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

238

2.53

10.15

1.3

1.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

5756

54893

1.22

10.12

5.6

4.7

6.2

6.0

mmol/l

22.79

5106

48765

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

3.55

10.12

1.1

1.4

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

227

2.56

10.09

1.7

2.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

227

2.56

10.09

1.7

2.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

4.09

10.08

1.9

2.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

3.69

10.06

1.8

1.7

—

(40768441) Liver Pathology biopsy report

358

2.21

9.93

1.6

1.3

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

161

2.86

9.92

1.4

1.2

—

(3004775) Volume in Urine collected for unspecified duration

437

2.09

9.88

2.3

2.1

818.3

631.0

2.14

284

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

146

2.95

9.79

1.6

1.5

0.3

0.4

ug/l

0.67

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

6.39

9.76

6.1

6.8

—

(4010399)

546

4104

1.35

9.75

1.5

1.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

231

2.51

9.74

1.8

2.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

407

2919

1.41

9.68

1.2

121.5

134.7

iu/ml

0.28

137

1045

(3028679) Herpes simplex virus Ab [Presence] in Serum

180

2.73

9.67

1.1

1.2

—

(40757373) Influenza virus identified in Isolate

111

3.24

9.63

1.6

1.5

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

4.42

9.49

1.1

—

(3014891) Appearance of Pleural fluid

3.61

9.46

1.6

1.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

307

2100

1.48

9.41

1.7

1.5

—

(3039443) Prostate specific Ag panel - Serum or Plasma

964

0.35

9.39

1.5

1.7

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

206

2.58

9.37

1.1

1.0

1.1

u/l

0.84

103

(21494814) CD8 cells/100 lymphocytes in Specimen

208

2.55

9.20

2.5

1.9

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

247

1625

1.53

9.14

1.5

1.4

—

(3000330) Specific gravity of Urine by Test strip

423

3088

1.39

9.08

5.8

3.7

—

(37019676) Renin [Units/volume] in Plasma --supine

9.15

8.94

1.1

22.1

26.8

mu/l

—

(3003327) Ova and parasites identified in Stool by Light microscopy

226

1467

1.55

8.90

1.6

1.7

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

140

806

1.75

8.84

3.7

2.3

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

7.21

8.80

1.1

1.4

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.84

8.62

2.0

2.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.99

8.56

1.2

1.1

—

(3000034) Microalbumin [Mass/volume] in Urine

498

1.93

8.48

2.6

95.5

25.0

mg/l

1.52

357

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

389

2.06

8.47

1.7

1.5

0.2

0.3

nmol/l

0.12

283

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

153

2.75

8.46

1.5

1.3

26.9

25.7

0.08

126

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

19.97

8.44

3.4

4.7

—

(3052592) Norovirus Ag [Presence] in Stool

126

2.94

8.42

1.1

1.2

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

3.26

8.41

2.4

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

121

2.98

8.39

2.3

2.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

3.87

8.36

3.0

2.4

0.6

u/field

0.04

(3017509) Phencyclidine [Presence] in Urine

5.76

8.28

1.3

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

413

3051

1.37

8.27

1.2

1.3

49.4

53.7

au/ml

0.08

147

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

4.07

8.20

1.3

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

4.20

8.14

1.0

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

263

1799

1.47

8.11

1.7

1.6

—

(40768443) Skin Pathology biopsy report

373

2721

1.39

8.07

1.2

—

(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid

17.11

8.05

5.8

5.1

15.8

18.2

mmol/l

—

(1761868) Lipid panel - Serum or Plasma

1472

16830

0.84

8.02

3.5

2.9

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1724

0.55

7.97

1.8

1.7

—

(4281824)

113

633

1.79

7.88

1.3

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

143

2.73

7.79

2.1

3.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

116

2.93

7.74

1.1

1.2

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

173

2.54

7.67

2.9

1.8

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

291

2.17

7.65

1.2

—

(3021788) Differential panel - Synovial fluid

172

1089

1.59

7.60

1.6

1.5

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

3.33

7.60

1.4

1.2

50.9

51.5

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

177

1134

1.57

7.45

1.6

1.4

29.5

32.9

iu/l

0.60

149

967

(3045424) Erythrocytes [Presence] in Urine

156

973

1.61

7.35

1.9

1.5

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1036

8723

1.21

7.35

1.3

42.1

37.3

iu/ml

0.38

350

2715

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

3.73

7.30

1.1

—

(3020491) Glucose [Moles/volume] in Blood

378

1.99

7.26

1.9

2.2

8.1

6.8

mmol/l

1.46

252

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

178

2.47

7.25

1.2

1.1

31.7

5.9

u/ml

—

(3028717) Thiamine [Mass/volume] in Blood

4.28

7.17

1.1

1.3

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

205

1374

1.50

7.04

1.3

92.0

43.5

u/ml

0.84

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

288

2.12

7.04

1.2

—

(4034850)

268

1894

1.43

7.01

15.3

10.3

—

(3048879) Bone marrow aspiration report

182

2.42

6.93

1.3

1.8

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

900

10637

0.82

6.92

2.9

3.1

0.8

ug/l

0.13

635

7346

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

4.35

6.92

1.4

1.1

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

4.35

6.92

1.1

1.3

42.3

42.4

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

311

2.06

6.87

2.1

1.8

0.9

2.5

u/field

1.65

201

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

3.33

6.78

1.2

1.3

53.6

84.6

ng/l

0.32

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

108

627

1.73

6.73

3.4

3.2

7.2

15.3

nmol/l

0.45

103

616

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

191

1275

1.51

6.71

1.3

3.9

5.2

u/ml

0.20

137

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.70

6.59

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

105

610

1.73

6.54

2.6

2.0

3515.3

3456.1

u/l

0.01

236

(3004616) Nuclear Ab [Presence] in Serum

111

656

1.70

6.50

1.4

1.3

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

5.19

6.45

1.0

1.2

4421.2

3886.7

ng/l

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

130

2.61

6.32

1.1

80.0

83.2

0.17

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

136

2.57

6.31

1.1

1.3

118.0

112.2

0.53

124

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

128

793

1.62

6.27

1.1

1.2

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

+∞

6.24

1.2

0.0

286.8

—

nmol/l

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

171

1135

1.51

6.21

1.2

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

162

1063

1.53

6.20

1.3

1.2

4.8

5.2

u/ml

0.05

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

190

1290

1.48

6.18

1.3

4.0

5.6

u/ml

0.60

222

(4024509)

110

663

1.66

6.02

1.9

1.6

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

441

3450

1.29

6.01

2.5

2.1

11.2

12.8

nmol/l

3.10

352

3049

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

128

2.58

5.98

1.1

80.9

84.0

0.13

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

4.81

5.94

1.2

1.3

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

129

2.56

5.90

1.2

1.3

94.0

139.5

nmol/l

1.45

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

257

2.06

5.78

3.2

3.0

41.7

39.0

0.32

100

(3033086) Enterovirus NOS Ab [Titer] in Serum

11.09

5.77

1.0

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

161

2.36

5.74

1.1

1.2

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

3.14

5.70

1.1

1.2

13.2

18.5

u/l

0.75

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

204

1432

1.43

5.62

1.3

1.2

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

115

2.61

5.59

1.0

1.2

0.7

umol/24h

0.15

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

195

2.21

5.57

1.0

1.1

—

(3045462) Protein/Creatinine [Ratio] in Urine

4.23

5.52

6.7

8.7

91.1

41.3

g/mol

0.43

(3034891) Synovial lining cells/100 cells in Synovial fluid

289

1.97

5.52

1.3

1.5

1.4

4.4

2.41

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

217

2986

0.72

5.52

1.3

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

128

2.50

5.48

2.3

2.4

6.9

7.4

mmol/l

0.47

(3000475) Leukocytes [#/volume] in Synovial fluid

208

1474

1.42

5.45

1.9

1.6

13091.3

15222.9

e6/l

0.37

148

1073

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

180

1242

1.46

5.44

1.1

4.9

11.6

u/ml

—

112

(4015189)

178

2.25

5.42

2.6

2.3

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

15.97

5.40

7.5

4.4

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

319

1.88

5.09

1.1

1.4

0.2

0.9

u/ml

1.14

168

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

4.19

5.06

1.2

1.1

1.4

5.0

u/l

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

169

1170

1.45

5.05

1.4

1.3

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

414

1.77

5.04

2.1

1.8

4.5

4.1

mg/l

0.27

391

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

116

746

1.56

4.95

1.5

63.4

58.9

0.56

479

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

282

1.92

4.85

1.1

1.2

12.2

nmol/l

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

346

1.82

4.85

1.8

1.7

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

4.57

4.75

1.4

1.7

1.4

1.1

mg/l

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

4.57

4.75

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

4.57

4.75

1.0

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

4.57

4.75

1.4

1.7

0.3

2.7

mg/l

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

3.40

4.71

1.3

3.0

—

(3000060) B lymphocytes [#/volume] in Blood

114

2.45

4.66

2.5

2.4

138.0

1480.0

e6/l

1.04

(1761482) Bacteria [#/volume] in Urine by Culture

228

1691

1.36

4.61

7.1

4.7

—

(3023511) Choriogonadotropin [Units/volume] in Urine

281

1.89

4.57

1.8

1.2

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

4.39

4.54

1.4

1.7

0.3

1.7

mg/l

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

3.05

4.48

1.2

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

3.14

4.45

1.5

1.8

48.6

44.3

umol/l

0.24

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

280

2153

1.31

4.43

1.7

1.8

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

128

863

1.49

4.43

1.2

1.3

219.9

208.8

miu/ml

0.08

344

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

3.99

4.41

1.0

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

3.71

4.34

1.0

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

3.19

4.30

2.0

2.3

1.2

mmol/l

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

245

1.92

4.29

1.6

1.4

—

(4146454)

597

1.58

4.29

3.1

2.5

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

11.64

4.26

1.9

2.0

—

(3050794) Legionella sp Ab [Presence] in Serum

3.86

4.23

1.0

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

3.86

4.23

1.8

3.5

—

(3025315) Body weight

3.86

4.23

5.8

4.4

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

100

647

1.55

4.21

1.2

3.4

3.7

u/ml

0.12

274

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

441

1.66

4.09

1.2

75.7

77.8

u/ml

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

128

2.26

4.08

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

128

2.26

4.08

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

128

2.26

4.08

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

128

2.26

4.08

1.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

443

1.65

4.03

1.2

30.3

43.0

u/ml

0.38

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

244

1.88

4.01

1.3

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

317

1.77

3.97

1.2

10.6

12.3

mmol/l

1.33

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

7.26

3.85

2.1

2.6

3.4

3.1

mg/l

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.76

3.82

1.3

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.76

3.82

1.3

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.76

3.82

1.3

1.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

396

1.67

3.82

1.5

1.2

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

5.99

3.80

1.2

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

5.99

3.80

1.2

1.5

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

3.06

3.78

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.83

3.76

1.0

—

(3023420) DNA double strand Ab [Units/volume] in Serum

475

1.60

3.76

1.8

1.3

54.1

22.5

iu/ml

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

136

961

1.42

3.75

1.3

1.2

54.1

43.1

u/ml

0.28

108

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.39

3.69

2.3

1.6

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

556

1.55

3.69

2.3

1.9

2.0

u/field

0.05

172

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

291

2312

1.27

3.63

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

3.11

3.62

1.0

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

3.66

3.61

2.1

1.5

6.6

3.9

nmol/l

0.39

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

2.47

3.60

1.2

1.1

89.2

75.5

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.74

3.56

1.0

—

(3022689) Creatine [Moles/volume] in Urine

117

2.22

3.54

2.3

1.4

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.44

3.52

1.1

1.2

—

(3044941) Cell count panel - Synovial fluid

131

932

1.41

3.50

1.6

1.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

929

8238

1.14

3.46

1.2

11.0

13.6

u/ml

0.54

325

3033

(3044009) aPTT.lupus sensitive (LA screen)

3.33

3.45

1.3

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

194

1.91

3.39

1.0

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.97

3.39

1.1

1.3

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

237

1.81

3.38

1.1

1.6

7.0

9.4

ug/l

0.50

209

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

102

1457

0.69

3.37

2.3

1.7

4.4

3.7

mg/l

0.32

1030

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

2.38

3.36

1.0

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

411

1.61

3.35

1.8

1.6

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

202

1.88

3.34

1.5

1.3

66.5

54.9

1.15

172

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

349

2861

1.23

3.32

4.6

3.8

109.4

79.3

u/ml

0.65

334

2744

(3035320) C reactive protein [Mass/volume] in Body fluid

389

1.62

3.31

3.2

2.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

155

2.00

3.26

1.6

1.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

509

1.53

3.25

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

122

2.13

3.22

1.2

1.1

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.57

3.18

1.3

1.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

593

1.49

3.17

1.3

8.2

54.4

u/ml

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.72

3.13

8.2

5.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

2.35

3.12

1.3

1.2

85.2

73.4

—

(3024263) Appearance of Synovial fluid

311

1.67

3.11

2.0

1.5

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.53

3.10

1.1

1.0

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

589

1.48

3.07

1.6

1.3

17138.7

133469.8

e6/l

3.92

404

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

329

1.64

3.02

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

329

1.64

3.02

1.1

—

(4094501)

102

1426

0.71

3.02

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

146

1.98

3.01

1.0

1.1

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

5.82

3.01

1.0

1.5

—

(3002619) Bacteria identified in Specimen by Culture

119

2.10

3.01

1.3

—

(1002224) Polysomnography panel

114

1563

0.72

3.00

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

330

1.64

2.99

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

331

1.63

2.96

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

331

1.63

2.96

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

331

1.63

2.96

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.74

2.96

2.7

2.3

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

3.14

2.91

1.0

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.39

2.77

1.1

1.0

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

3.22

2.75

1.1

1.2

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

8.31

2.74

1.2

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

5335

51953

1.09

2.63

4.5

3.9

1.3

mmol/l

0.50

4684

46093

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

3.12

2.63

1.0

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

289

0.41

2.57

1.4

1.5

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.89

2.56

1.0

1.1

6.2

10.3

u/l

0.90

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

291

2414

1.21

2.54

1.7

1.8

—

(3018291) Platelet Ab [Presence] in Serum

7.12

2.54

1.6

1.0

—

(4268621)

442

1.49

2.52

2.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

657

1.40

2.51

1.2

3.1

4.2

u/ml

0.33

217

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

455

5216

0.86

2.49

1.6

—

(3050129) First trimester maternal screen panel - Serum or Plasma

392

0.51

2.47

1.3

1.4

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.81

2.46

1.0

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

151

1.85

2.44

1.1

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

4.99

2.39

1.7

1.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

605

1.41

2.38

1.1

—

(4306422)

622

1.40

2.38

1.2

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.33

2.38

1.1

1.0

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

3.33

2.38

1.9

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.74

2.35

1.5

1.9

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

3.63

2.35

2.0

2.3

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

2.06

2.34

1.9

3.5

—

(3025549) Creatine [Moles/time] in 24 hour Urine

2.60

2.34

1.5

1.3

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

2.60

2.34

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

634

1.39

2.31

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

133

1.88

2.28

1.9

1.7

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.55

2.25

1.0

1.2

2.1

1.8

umol/24h

0.20

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

141

1.84

2.24

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

141

1.84

2.24

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

406

1.48

2.22

1.0

786.7

717.2

ng/l

0.54

262

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

406

1.48

2.22

1.0

200.3

354.3

ng/l

13.90

270

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

589

1.39

2.21

1.1

119.9

115.7

0.54

527

(3013139) Helicobacter pylori Ag [Presence] in Stool

417

3623

1.16

2.16

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1379

14710

0.92

2.13

4.2

4.4

21.5

21.9

0.41

664

7663

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

410

1.46

2.13

1.0

29.0

48.0

ng/l

8.34

269

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.29

2.12

1.1

—

(3000492) Spirometry study

523

4623

1.14

2.12

1.6

1.5

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

838

7617

1.11

2.11

4.8

4.4

35.9

33.1

8.06

572

4906

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

3.19

2.08

1.5

1.0

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

355

1.49

2.08

4.0

4.5

266.0

132.4

u/ml

0.23

105

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

145

1.79

2.08

1.3

1.9

156.9

175.2

0.65

136

(4212803)

2.39

2.01

1.2

1.0

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.63

1.99

1.1

—

(3000285) Sodium [Moles/volume] in Blood

104

1.92

1.98

1.6

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.95

1.98

1.3

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

133

1.80

1.97

1.5

1.6

9.9

8.7

ug/l

0.79

133

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

217

1.61

1.94

1.2

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

2.18

1.92

1.1

1.2

108.9

91.6

ug/l

—

(40768800) Prostate Pathology biopsy report

1206

0.76

1.92

1.2

—

(3019174) dRVVT (LA screen)

2.56

1.90

1.3

1.2

—

(3006270) Folate [Moles/volume] in Blood

555

1.37

1.90

1.4

1.2

312.8

337.2

nmol/l

0.45

447

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

166

1347

1.23

1.89

1.8

1.7

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

106

1.88

1.3

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

2.00

1.88

1.3

1.6

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

3.17

1.87

1.0

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

558

1.36

1.85

1.1

3.0

4.0

u/ml

0.34

212

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

180

0.44

1.80

1.6

1.4

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

3.04

1.79

1.0

196.1

294.3

nmol/l

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

2.57

1.79

1.0

1.8

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.05

1.78

1.9

1.5

—

(44813793)

311

1.48

1.77

1.0

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

247

1.54

1.75

1.1

1.2

1.1

ratio

0.63

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.43

1.74

1.5

1.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

117

1.79

1.72

1.0

1.1

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

3.84

1.71

1.0

1.5

300.7

469.2

nmol/l

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

3.84

1.71

2.2

1.5

176.0

117.7

umol/l

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.05

1.68

1.1

1.0

—

(3027035) Albumin [Mass/time] in 24 hour Urine

2.38

1.66

1.1

1.4

—

236.3

—

(3001556) Androgen free Index in Serum or Plasma

3.15

1.65

1.2

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

104

1.82

1.65

2.1

1.9

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

104

1.82

1.65

1.4

113.8

117.7

ng/l

0.06

104

(3002256) Pathology report gross observation

809

7439

1.09

1.65

1.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

727

6657

1.10

1.62

1.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

211

0.47

1.62

1.3

1.5

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

310

1.45

1.60

1.4

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

2.14

1.59

1.0

24.5

12.5

iu/ml

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

167

1.61

1.56

4.3

5.7

66.8

70.3

0.23

132

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

3.32

1.52

1.2

1.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.83

1.44

19.9

7.3

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

3.12

1.43

1.0

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

2.60

1.36

1.5

1.1

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.93

1.35

1.2

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

2.93

1.35

1.0

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1909

18266

1.06

1.29

4.7

5.1

4.1

3.7

ug/l

0.25

1644

16324

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.77

1.28

1.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

2.77

1.28

1.0

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

5534

54415

1.06

1.27

4.9

4.4

4.3

4.7

mmol/l

99.34

4922

49116

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.78

1.25

1.1

1.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

5678

55886

1.06

1.23

5.4

4.9

2.4

2.7

mmol/l

154.55

5034

50121

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

325

0.64

1.22

1.5

1.4

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

100

1.70

1.22

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.30

1.18

1.7

1.3

—

(40758292) HTLV I+II Ab panel - Serum

1.83

1.18

1.5

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

102

1.66

1.14

19.9

7.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

240

1.41

1.13

5.7

5.9

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

199

1.45

1.12

1.3

1.6

3.3

5.0

ug/l

0.48

145

(3038177) Helicobacter pylori Ab [Presence] in Serum

716

1.23

1.09

1.3

—

(3029075) Extractable nuclear Ab panel - Serum

135

1.55

1.09

1.0

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.72

1.07

2.2

2.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

326

0.67

1.07

1.5

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

326

0.67

1.07

1.5

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

326

0.67

1.07

1.5

1.4

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.68

1.06

1.1

1.3

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.92

1.05

1.2

1.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

655

6968

0.93

1.01

1.4

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.89

0.93

1.9

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

350

0.71

0.93

1.4

1.5

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

630

0.79

0.91

1.3

1.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

132

1139

1.16

0.90

2.0

1.8

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

266

0.67

0.90

1.6

1.4

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

287

1.32

0.89

2.3

2.1

73.3

64.0

ug/min

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

136

1179

1.15

0.88

1.7

1.5

372.1

193.9

pmol/l

0.75

127

1148

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

128

0.54

0.88

1.0

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

275

0.69

0.86

1.5

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

106

904

1.17

0.85

1.8

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

104

1.53

0.83

5.1

4.9

35.0

38.8

u/l

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

121

1386

0.87

0.82

1.3

—

(3036071) Salmonella sp Ab [Titer] in Serum

129

1.47

0.82

1.1

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

430

0.76

0.80

11.8

2.9

13.9

13.3

1.76

425

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.79

0.0

1.0

—

0.2

—

(3026470) Cobalt [Mass/volume] in Blood

456

1.23

0.76

1.9

3.0

3.6

ug/l

0.27

400

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

255

0.70

0.75

1.7

—

(3051101) Glucose [Moles/volume] in Cord blood

131

0.61

0.73

5.6

6.4

—

(3005033) Fetal Nuchal fold Thickness US

265

0.71

0.73

1.5

1.4

—

(40768795) Lymph node Pathology biopsy report

568

1.20

0.73

1.2

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.99

0.72

1.4

221.2

339.3

umol/24h

—

(44806420)

184

1.36

0.72

2.1

2.4

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

237

1.31

0.70

1.1

1.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

330

0.75

0.69

1.4

31.6

165.8

pmol/l

0.70

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.85

0.68

1.4

1.3

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.85

0.68

1.2

1.1

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.63

0.67

33.0

8.9

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.59

0.67

7.6

7.5

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.78

0.66

1.8

1.3

—

(3008898) HLA-B27 [Presence]

114

1284

0.88

0.65

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.53

0.64

1.3

1.6

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

235

0.72

0.64

1.0

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

5454

53894

1.03

0.63

4.9

4.3

1.5

mmol/l

1.15

4817

48299

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

865

1.14

0.63

2.1

1.8

178.4

207.4

pmol/l

1.48

823

(44806071)

1.60

0.61

1.3

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

617

1.16

0.60

1.1

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.60

0.0

1.1

—

8.0

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

167

1.31

0.55

1.0

1.1

0.9

1.9

u/ml

—

(3025577) Chromium [Mass/volume] in Blood

447

1.18

0.55

2.1

2.0

1.7

2.4

ug/l

1.08

373

(3001729) Color of Synovial fluid

1.50

0.54

1.4

1.5

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

302

1.22

0.54

2.3

1.5

0.9

g/l

0.68

302

(3034426) Prothrombin time (PT)

151

1.32

0.52

1.4

1.2

—

(3003338) MCHC [Mass/volume]

4507

45377

0.97

0.52

45.4

19.1

333.7

331.5

g/l

38.89

4466

44900

(3039744) RNA polymerase III Ab [Units/volume] in Serum

1.50

0.51

1.2

1.1

—

5.5

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

602

1.14

0.49

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

180

1.27

0.48

1.1

0.8

0.9

u/ml

0.16

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1076

0.90

0.48

1.4

1.5

—

(1617658) Protocol used for examination of sentinel lymph nodes

481

0.85

0.45

1.0

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1416

14445

0.97

0.44

1.7

1.6

1.4

1.3

mmol/l

0.82

1152

11803

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

554

0.86

0.44

1.2

8.3

7.6

mmol/l

0.76

395

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

183

1.25

0.43

1.0

1.1

96.4

94.0

0.21

139

(3051387) C reactive protein [Mass/volume] in Capillary blood

140

1284

1.09

0.43

5.2

3.6

24.7

29.7

mg/l

1.11

786

(4211845)

331

1.18

0.41

5.1

3.6

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

0.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

130

1193

1.09

0.41

1.8

1.7

54.8

43.3

nmol/l

3.37

123

1152

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

0.2

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.40

0.0

1.2

—

(40765096) Chromosome analysis panel by Banding

186

1.23

0.39

1.2

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.32

0.37

1.0

1.1

—

(3006462) Nitrate [Presence] in Urine

307

1.17

0.37

4.9

3.7

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

107

980

1.09

0.36

4.3

3.7

48.8

46.9

u/ml

0.04

102

943

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.39

0.35

1.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

389

0.87

0.31

1.1

1.6

3.6

u/ml

1.12

153

(40765089) Chromosome analysis panel - Blood by G-banded

1.29

0.30

1.0

—

(3020650) Glucose [Presence] in Urine

157

1.21

0.28

1.4

1.5

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

469

0.89

0.28

1.2

1.1

0.3

2.6

u/ml

—

108

(3015183) Erythrocyte sedimentation rate

172

0.81

0.28

1.4

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.27

0.27

1.9

1.7

—

(3035933) Granulocytes/100 leukocytes in Blood

112

1.25

0.27

5.6

1.6

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

128

0.78

0.27

2.4

1.6

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

253

1.14

0.25

1.0

1.1

8.3

10.8

iu/ml

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

106

1.22

0.22

1.0

1.1

0.7

9.7

u/ml

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.25

0.22

1.2

1.5

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

10171.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.16

0.21

1.0

5.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

1.21

0.19

1.3

3.1

246.6

180.6

ng/l

—

(3011897) Casein IgE Ab [Units/volume] in Serum

1.15

0.19

1.0

1.2

—

1.6

—

(3036670) Protein [Mass/volume] in Synovial fluid

203

1.13

0.18

1.3

1.2

38.2

39.6

g/l

—

108

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

137

1.16

0.18

1.1

—

(40762814) Titanium [Mass/volume] in Blood

128

1.17

0.17

2.1

4.2

3.7

ug/l

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

128

1.17

0.17

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

609

1.06

0.17

1.2

1.1

0.8

1.6

u/ml

0.85

261

(3002523) Influenza virus A Ag [Presence] in Specimen

551

1.07

0.16

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

556

1.06

0.13

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

221

1.08

0.10

1.0

1.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

221

1.08

0.10

1.2

1.3

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.08

0.09

1.2

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.80

0.08

1.0

1.1

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

0.77

0.08

1.0

1.1

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

129

1.08

0.05

1.2

1.5

1.8

2.2

ug/l

—

(4133840)

130

0.92

0.05

1.8

1.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

352

0.96

0.04

1.1

0.7

3.6

u/ml

2.96

141

(40768793) Breast Pathology biopsy report

134

1347

0.99

0.02

1.3

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

527

0.98

0.01

1.1

4.3

u/ml

3.40

274

(3025130) Human papilloma virus identified in Specimen

480

1.02

0.01

1.6

—

(3037556) Urate [Mass/volume] in Serum or Plasma

190

1.00

0.00

1.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

307

1.01

0.00

1.2

1.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.04

0.00

4.0

2.0

—

(3009871) Measles virus Ab [Titer] in Serum

132

0.98

0.00

1.6

1.8

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

310

1.00

0.00

1.1

0.1

0.3

u/ml

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

296

1.01

0.00

1.1

1.2

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

120

1.00

0.00

1.3

1.5

7.8

8.7

mmol/l

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

508

1.00

0.00

1.1

0.5

1.1

u/ml

1.04

235

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

1.2

—

(3008343) Lysozyme [Mass/volume] in Urine

0.00

0.0

1.0

—

0.5

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.0

1.0

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.0

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

0.98

0.00

1.8

2.6

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

0.00

0.0

1.2

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

7.1

—

0.2

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.0

1.8

—

5.7

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint E4_HYPOOSMNAT and mortality.

Females

Parameter	HR [95% CI]	p-value
E4_HYPOOSMNAT	1.818 [1.65, 2.01]	< 0.001
Birth year	0.994 [0.99, 1.0]	0.155

During the follow-up period (1.1.1998 — 31.12.2019), 18945 out of 38171 females with E4_HYPOOSMNAT died.

Males

Parameter	HR [95% CI]	p-value
E4_HYPOOSMNAT	3.849 [3.34, 4.44]	< 0.001
Birth year	0.986 [0.98, 1.0]	0.004

During the follow-up period (1.1.1998 — 31.12.2019), 10179 out of 20213 males with E4_HYPOOSMNAT died.

Mortality risk

Mortality risk for people of age

years, who have E4_HYPOOSMNAT.

N-year risk	Females	Males
1	0.202%	0.881%
5	0.978%	4.201%
10	2.405%	10.121%
15	4.636%	19.417%
20	8.313%	30.311%

Relationships between endpoints

↥

Index endpoint: E4_HYPOOSMNAT – Hypo-osmolality and hyponatraemia

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Hypo-osmolality and hyponatraemia

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints